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Abstract
MicroPhysiological Systems (MPS) show significant promise in speeding drug devel-
opment and advancing basic research. They may serve better than animal models for
obtaining accurate human response data and thereby reducing failed clinical trials.
The CN Bio LiverChip is one such commercial MPS device which cultures liver cells on
a perforated polystyrene scaffold and actively circulates cell culture medium through
them. Reducing the total circulating volume is desirable to increase the concentra-
tion of difficult-to-detect compounds, improve autocrine signaling, and achieve more
physiologically relevant drug decay times. However, achieving adequate oxygenation
at lower volumes is challenging due to surface tension effects.
This thesis describes an open-well, flow-through MPS platform with a low-volume
oxygenator, at a total circulating volume of approximately 500 µL. The oxygenator
uses the interior corner of a hydrophillic spiral to constrain the circulating fluid and
to create a thin fluid region, which decreases the diffusion depth relative to exposed
surface area, thereby improving oxygenation. The oxygenator performs equivalently
to the LiverChip at a fraction of the volume, and features a downward slope that
prevents fluid from accumulating in the oxygenator, which could deplete the cell
culture well. The fluidic configuration and other design considerations are described,
as well as hardware testing results and improved methods for preventing fluid from
bypassing the scaffold.
This project was supported by NIH grant number UH3-TR000496.
Thesis Supervisor: David L. Trumper
Title: Professor, Mechanical Engineering
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Chapter 1
Introduction
This thesis describes the process of developing an actively perfused cell culture
platform capable of providing adequate oxygenation to 600k human liver cells in a 500
𝜇L circulating media volume, as shown in Figure 1-1. The project is an extension of
work done in the Griffith lab at MIT [1, 2, 3] that led to the LiverChip platform (CN
Bio Innovations, Welwyn Garden City, UK), a commercial device with a circulating
volume of 1.2 mL. The primary contributions of our new work are: (1) the develop-
ment of a volume-limited free-surface oxygenator that maintains a defined fluid path
even at very low volumes, (2) fluid flow configurations that allows this oxyygenator
to interface with a cell culture scaffold, and (3) concepts and prototyping of sealing
methods to prevent fluid from bypassing the scaffold in a more robust manner than
in the existing LiverChip system.
This chapter provides motivation for the project and background relevant to the
design, gives an overview of the design and preliminary testing that make up this
thesis work, and describes the system-level requirements that apply to all of the sub-
systems described in subsequent chapters. Chapter 2 describes design and testing
of the oxygenator, the design challenge central to this work. Chapter 3 describes
development of the flow circulation configuration that connects the oxygenator to the
cell culture environment. Methods considered for fixing the cell scaffold in place and
preventing media from bypassing the cells are outlined in Chapter 4, and the inte-
grated platform design is discussed in Chapter 5. Finally, in Chapter 6 we conclude
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Figure 1-1: This CAD rendering shows the platform consists of a fluidic top plate
(polysulfone) and a pneumatic bottom plate (acrylic) separated by an elastomeric
polyurethane membrane. Each of six replicate lanes consists of an oxygenator spiral,
an MPS well, and a supply and effluent reservoir for the programmable media ex-
change. Three diaphragm pumps per lane control media exchange, oxygenator flow
rate, and the MPS flow rate (perfusion rate through the scaffold), respectively. The
pneumatic channels are coupled across lanes, so the flow rates in each lane are nom-
inally the same for a given one of the three functions. A standard tissue culture lid
(not shown) covers the wells to reduce contamination risk.
with specific suggestions for future development, including a fluidically closed system
that would allow further reduced circulating volumes.
1.1 Open-Well MicroPhysiological Systems
In the long and costly process of developing a new drug, an important challenge
is screening drugs for toxicity and efficacy before clinical trials. Animal models are
limited in their translation to human physiology, which has caused failures in clini-
18
cal trials and may cause viable drugs to be rejected [4]. MicroPhysiological Systems
(MPS), or small-scale in-vitro systems that recapitulate some aspect of human phys-
iology with human cells, show significant promise for drug screening assays as well as
applications in basic research [4, 5].
Open-well systems culture cells in a manner that allows ready access to the cells,
and has an unconstrained fluid-air interface. Closed-volume systems, by contrast,
offer contained volumes that allow easier fluid handling, but access to the cells is
often more difficult.
The Griffith Lab has developed multiple open-well platforms with on-board pump-
ing that allow easy access to the cells for seeding, sampling, or transfer to and from
the platform, using either standard Transwell-type cell culture inserts or an actively
perfused scaffold [1, 2, 6]. CN Bio Innovations has commercialized one of these plat-
forms as the LiverChip, which consists of 12 replicate lanes, each perfusing media
through a polystyrene scaffold on which the hepatocytes (liver cells) are grown.
1.2 Motivation for Low Circulating Volumes
The LiverChip perfuses the cells with a circulating volume of 1.2 mL of growth
medium, which contains nutrients and growth factors, and which transports oxygen
from the free air-liquid interface to the cells. A smaller circulating volume is desirable
to avoid the dilution effect of larger liquid volumes for three reasons: (1) biomarkers
produced in low quantities will be easier to detect; (2) intercellular communication
will be promoted if autocrine compounds are less dilute; (3) less drug mass will be
required to achieve the same initial concentration, and the drug exposure over time
will be closer to that for humans in vivo.
The main challenge with reducing volume in an open well format is the dominance
of surface tension at small length-scales. Simply putting less medium in the LiverChip
causes the fluid to wet the corners of the oxygenator channels, no longer providing
the surface area required to adequately oxygenate the cells. A 500 𝜇L target is less
than half the LiverChip circulating volume, and we estimated this is about as low as
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we could achieve in an open-well format. Circulating volumes less than 500 𝜇L will
likely require moving to a closed-volume format, concepts for which are presented in
Chapter 6.
1.3 Oxygenation Approaches
Oxygenating cell culture media can be broadly divided into two approaches: 1)
solid-liquid interface, such as membrane oxygenation, and 2) gas-liquid interface,
such as culturing in a static dish or bubbling a gas through the liquid (sparging).
Microcarriers that simulate the oxygen-storing capacity of hemoglobin in the blood
have been described [7, 8]; while these allow greater oxygen storage density, the oxygen
must still be replenished for long-term culture.
1.3.1 Solid-Liquid Interface
Many microfluidic and organ-on-chip systems are fabricated from PDMS (Poly-
dimethylsiloxane, a silicone rubber). PDMS can be poured into 3D printed molds
with fine feature resolution, which allows for faster prototyping than with materials
that require machining or etching. It can be bonded to itself and to glass by plasma
surface activation, it is relatively biologically and chemically inert, and it is highly
permeable to oxygen relative to other polymers [9]. This last property has led to
the use of thin PMDS membranes in extracorporeal membrane oxygenators (ECMO)
used in medical contexts to oxygenate blood [10, 11]. Many microfluidic oxygenators
and cell culture devices also use PDMS as the bulk material, membrane material, or
both [12, 13, 14].
While its fabrication and gas transport properties are favorable, PDMS is severely
limited in contexts where measurement or control of lipophillic drug, drug metabo-
lite, or biomarker concentrations are important, as required in many MPS devices
[5]. These compounds both adsorb onto and absorb into PDMS, making the concen-
tration in the local cell environment difficult to predict, measure, or interpret [15].
The platform described in this thesis is ultimately intended for experiments where
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Figure 1-2: Cross-section showing inline circulation on the CN Bio LiverChip during
downward flow. The oxygenator consists of a wide channel with enough exposed
surface area to oxygenate the media as it travels back to the MPS.
such binding is not acceptable. For our purposes, oxygenation membrane materials
are therefore effectively constrained to nano-porous Polycarbonate [16], micro-porous
polypropylene or PTFE [17], or diffusive Dupont Teflon AF [17], which are minimally
interactive.
1.3.2 Gas-Liquid Interface
The standard approach for oxygenation of open-well static culture is by passive
diffusion through an exposed surface. A culture lid increases sterility but allows
oxygenation by overhanging the edge of the dish or well-plate; oxygen diffuses up
the vertical air column, but bacteria, which sink in still air, are passively excluded.
The primary factor affecting oxygenation is then the surface area of the air-medium
interface relative to the depth of diffusion.
This passive interface oxygenation method has been used for open well systems
with active circulation and mixing [6], as well as active perfusion through cell scaffolds
[2]. The LiverChip platform uses a "tail," a shallow elongated channel that increases
the exposed surface area, to provide oxygenation (see Figure 1-2). Inman [1] describes
the development of these oxygenator channels in more detail.
Several methods have been described to increase oxygen uptake in a free-surface
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cell culture environment, such as roller bottles, shakers, other agitation methods [18],
but these are not feasible options for very low fluid volumes. Sparging (bubbling
gas through a reservoir of the fluid to be oxygenated) can increase gas-liquid surface
area by introducing small bubbles, but this also requires a reservoir of medium and
a method of containing the foaming that can be produced.
1.4 Project Summary
The objective of the work described in this thesis is to design an organ-on-chip
platform capable of adequately oxygenating and culturing at least 250k rat
or 600k human liver cells in a flow-through, open-well environment with
a total circulating volume of 500 𝜇L or less. Specific functional requirements
of the system are described in Section 1.5, after the following overview.
1.4.1 System Overview
The Six-replicate Reduced-volume Liver (6xRL) platform developed for this thesis
is shown in the photographs in Figure 1-3. This new platform uses a format similar
to other devices from the Griffith lab [2, 6], with a non-sterile acrylic pneumatic plate
and a sterile polysulfone fluidic plate separated by a sterile polyurethane membrane,
which allows circulation of the media in the fluidic plate by means of pneumatic
diaphragm pumps, shown in Figure 1-4. A media exchange system, consisting of a
fresh media reservoir, a pump, and passive spilling into an effluent collection reservoir,
replenishes nutrients and flushes out waste products. The platform configuration is
shown in Figure 1-1, and the integration of the system components is discussed in
Chapter 5.
To oxygenate the media through a free air-liquid interface while constraining the
fluid path and limiting the volume that can collect in the oxygenator, we invented a
spiral oxygenator that captures the fluid in the corner of a spiral cut into hydrophillic
polysulfone, as shown in Figure 1-5. The corner serves to limit the maximum thickness
of fluid that oxygen must diffuse into, and the spiral provides enough length in a small
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Figure 1-3: A photograph of the 6xRL revision 2 platform. The acrylic pneumatic
plate is shown at left, and the fluidic top plate is shown at right.
Figure 1-4: A section of the diaphragm pump geometry. A central pump chamber
and two valves allow for bi-directional volume-determined flow. See Inman [19] for
detail on the pump operating principle.
footprint for the fluid to exit the spiral adequately oxygenated. The oxygenator is
discussed in detail in Chapter 2.
The cell seeding protocol requires that flow be down through the cell scaffold,
which is shown in Figure 1-6, for the first eight hours to allow cells to attach, and then
upwards for the remainder of the experiment to prevent the cells from occluding the
scaffold channels. To allow the oxygenator to self-empty (thereby preventing volume
from accumulating in the oxygenator and allowing the cells to dry out), the oxygenator
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Figure 1-5: The revision 2 oxygenator. Fluid (dyed red) enters the oxygenator through
the hole at left and flows counter-clockwise down a descending spiral through a channel
formed by surface tension forces pulling fluid into a corner. The fluid spills over into
the MPS well, and the continuous fluidic connection ensures a pressure drop 𝜌𝑔ℎ that
prevents fluid from accumulating in the oxygenator, and also serves to thin out the
fluid profile, thereby decreasing diffusion depth and improving oxygenation.
is used in unidirectional flow circuit which is separated from the bidirectional scaffold
perfusion flow circuit. To maximize the oxygenation of the media going to the cells
during upward flow, the media intake is placed directly under the oxygenator output.
To maximize the oxygen uptake in the oxygenator, the oxygenator intake is located
on the opposite end of the MPS, where the concentration is expected to be lower. A
schematic of this "selective sourcing" flow configuration is shown in Figure 1-7. This
and other configurations we considered are discussed in Chapter 3.
On the LiverChip, the scaffold is held in place with a polypropylene retaining ring
that is slightly larger in diameter than the well it sits in (see Figure 1-6 on the left).
Because this ring does not create any defined seal, fluid has been observed to flow
around the scaffold when using scaffolds of higher flow resistance than the standard
one. This is resolved in our new design by using a chamfered retaing ring and a
Viton gasket, a configuration which can seal up to 40 kPa, well above the anticipated
pressure drop. Alternative designs for securing the scaffold, including promising non-
elastomeric methods worth future consideration, are discussed in Chapter 4.
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Figure 1-6: The scaffold assembly for the LiverChip (left) and reduced volume Rev2
platform (right). Both platforms use the same polystyrene scaffold (CN Bio Innova-
tions, Welwyn Garden City, UK) and filter (Durapore 5 𝜇m SVPP membrane filter,
MilliporeSigma). Cells are initially seeded above the scaffold while the fluid is flowing
downward and collect in the scaffold pores where the filter prevents them from passing
through. The scaffold support prevents the filter from deflecting, which would allow
the cells to move in between the filter and scaffold. After eight hours, the cells have
attached to the scaffold walls and the flow is reversed to prevent cell growth from
clogging the pores. The retaining ring holds the assembly in place and is intended
to prevent fluid from flowing around the scaffold and bypassing the cells. The Rev2
assembly improves this sealing function by using a Viton gasket. The membrane ca-
pacitor, in combination with the filter and scaffold resistance, reduces the pulsatility
of the flow, reducing the peak pressure below the scaffold (the membrane is not shown
for the LiverChip on the left).
1.4.2 Results
Full characterization of the device is not yet possible due to the pneumatic chan-
nels fracturing during manufacturing. A revised version that is expected to solve
this problem is not yet fabricated at the time of writing. Characterization of the
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Figure 1-7: Selective sourcing. During seeding, media flows down through the cells,
where oxygen is consumed, then from 1 to 2. A mixture of media from 3 (high oxygen
concentration) and 2 (low concentration) then flow both back through the cells, and
also to 4, which feeds the oxygenator. After flow reversal, the cells are fed by media
sourced from 2, which is a mix of high concentration from 3 and low concentration
from the cells. The position of 2 directly under the oxygenator output 3 increases
the ratio of high to low concentration media, so the cells see an oxygen concentration
above the bulk average in the well. At the input to the oxygenator (4), the opposite
occurs, pulling media that is below average oxygen concentration.
oxygenator and selective sourcing layout were, however, possible.
The 6xRL revision 2 oxygenator performed better or the same as the CN Bio
LiverChip, but with better control of the fluid at less than a quarter of the volume held
in the oxygenator (we estimate closer to one eighth). The oxygen concentration that
actually reaches the cells, however, depends the flow direction. For downward flow, a
conservative fully mixed model in Chapter 3 suggests that the oxygen concentration
going to the cells in steady-state will be a maximum of 125 𝜇M, which does not meet
the 150 𝜇M requirement. After 8 hours, when upward flow begins, an experiment
with the revision 1 6xRL prototype indicates that the requirement will be met and
oxygenation will be better than on the LiverChip for the remainder of the experiment.
The circulating volumes are within 50 𝜇L of the 500 𝜇L target.
Several methods of sealing the scaffold were explored. The elastomeric approach
was chosen as the best initial solution, as it is readily implemented and satisfies
the sealing requirement of 40 kPa. However, experiments involving compounds that
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adsorb to Viton may require a different sealing approach.
The other design requirements described in this thesis were met either by our new
designs or by using existing approaches that have been proven on similar platforms,
such as the pneumatic pumping or existing sterile technique.
1.5 System Design Requirements
Together with the background presented above, the requirements presented in
this section provide context for the platform design. These requirements relate to the
overall function of the device, and hold across the different sub-systems.
1. Device must be cell- and drug-compatible
The need to avoid cytotoxicity and absorption of lipophilic drugs nar-
rows the range of allowable materials for media-contacting components.
Further, the platform material must be sterilized; steam (autoclave) is
preferable for its convenience and speed, but other methods may be
used if required. The existing reusable organ-on-chip platforms used
by the Griffith lab are machined from autoclavable Polysulfone (PSU)
with a thermoplastic polyurethane (TPU) membrane sterilized by ethy-
lene oxide gas (EtO); other acceptable materials include teflon/PTFE,
polystyrene, COC, and stainless steel.
2. The total circulating volume should be less than 500 𝜇L
Given the benefits of lower media volume described above, 500 𝜇L is
chosen as close to the minimum volume achievable with an open-well
platform.
3. The platform should provide controlled media exchange with at least
500 𝜇L capacity
27
At lower volumes, the depletion of nutrients by the liver cells and accu-
mulation of waste products becomes more significant, and batch media
exchange (full removal and replacement of media at one time, as is done
on the LiverChip ), may cause unwanted spikes in metabolic activity.
Continuous or programmable media exchange is therefore desired to re-
place the media more frequently. 500 𝜇L would allow for replenishment
of the media reservoir daily.
4. Sterility of media must be maintained during operation
Cell seeding and media exchange can be done in a sterile Biological Safety
Cabinet (BSC) with standard precautions. The platform will therefore
need to be transported between incubator and BSC without contamina-
tion, as is required with the earlier platform designs.
5. The platform should be compatible with a standard tissue culture lid
If no oxygen measurement is required, the platform should be compatible
with standard pre-sterilized lids. The current lid used with the LiverChip
platform is the Costal universal lid (Corning Product #3099).
6. The platform should integrate with existing pneumatic infrastructure
To simplify use in the Griffith lab, the platform should be compatible
with 1/8th inch OD pneumatic tubing and driven by the existing pneu-
matic controllers, as used in earlier platforms.
These requirements constrain the materials and workflow of the design, as well as
how the different subcomponents integrate with each other. In the following chapters,
we present the different subsystems and their own specific requirements, beginning
with the requirements, design, and testing of the oxygenator.
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Chapter 2
Low-Volume Oxygenator
The oxygenator design is the central challenge of this thesis, and is critical to the
goal of culturing hepatocytes at low circulating volumes. In this chapter, requirements
for the oxygenator are listed (Section 2.1), followed by concepts (Section 2.2), concept
selection (Section 2.3), prototyping (Section 2.4), modeling of the oxygen diffusion
process within the oxygenator (Section 2.5), and testing (Section 2.6).
2.1 Oxygenator Requirements
The requirements that informed the oxygenator design processes are described
below.
1. Oxygenation Potential (𝜑) greater than 0.8 at 1 𝜇L/s
This requirement aims to ensure that the oxygenator performs as well as,
or better than, the CN Bio LiverChip oxygenation channel, which is taken
as a benchmark. The oxygenation potential 𝜑, described in more detail
in Section 2.5, is defined as the change in oxygen concentration (𝐶ℎ𝑖𝑔ℎ−
𝐶𝑙𝑜𝑤) across the oxygenator, normalized by the maximum possible change
(𝐶𝑠𝑎𝑡 − 𝐶𝑙𝑜𝑤):
𝜑 ≡ 𝐶ℎ𝑖𝑔ℎ − 𝐶𝑙𝑜𝑤
𝐶𝑠𝑎𝑡 − 𝐶𝑙𝑜𝑤 . (2.1)
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Here, 𝐶𝑙𝑜𝑤 is the oxygen concentration at the oxygenator inlet, 𝐶ℎ𝑖𝑔ℎ is
the concentration at the outlet, and 𝐶𝑠𝑎𝑡 is the fully saturated concen-
tration. The parameter 𝜑 is a non-dimensional measure of oxygenator
efficiency that varies from 0 to 1. It will be demonstrated in Section 2.5
that 𝜑 is flow-rate dependent, but independent of inlet concentration. In
an experiment with 250,000 rat hepatocytes (described in appendix C),
the oxygenation potential of the LiverChip was determined to be 0.8 at
1 𝜇L/s. This value is used as a benchmark. After the oxygenator design
was developed it became clear that during the initial eight hour cell seed-
ing period, 𝑄𝜑 ≥ 4 𝜇L/s is a better equivalency requirement, while the
𝜑 ≥ 0.8 requirement is appropriate after seeding. See Sections 3.4 and
3.6 for more details, and a discussion of mixed vs. inline configurations).
2. Bubble clearing
Gas bubbles trapped under the scaffold can cause cell death by displacing
media and therefore starving the cells, and can also cause increased fluid
shear stresses, as the same volume flow rate of liquid passes through a
smaller area. To lower this risk, the media exiting the oxygenator should
be bubble-free.
3. Flow should resume without depleting the MPS volume after stopping
for 5 minutes
During an experiment, the oxygenator will not be stopped for more than
approximately one minute. The cells must remain oxygenated, so trans-
portation of the chip between incubator and bio-safety cabinet must be
brief, and both locations must have pumping capability. The cells’ need
for oxygen therefore limits the duration that the oxygenator can be stag-
nant. Five minutes is chosen as a requirement with an acceptable safety
margin.
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Spontaneous wetting of a dry oxygenator path is ideal, but not strictly
necessary. Propagation of the fluid path along a dry channel is a con-
stant balance of forces. If advancing the fluid front requires substantial
pressure behind it due to hydrophobicity, the advancing channel of fluid
can hold significant volume and potentially spill in undesired directions.
This volume must also not be so great as to deplete the MPS and dry
out the cells. Further, after an initial priming, the oxygenator must not
run dry, even after a five minute duration of stopped flow.
4. Volume-limited
To avoid storing fluid volume and therefore depleting the MPS and risk-
ing cell death, the oxygenator must not allow excess volume to accumu-
late.
2.2 Oxygenator Concepts
The following concepts were considered as methods to oxygenate media before
returning it to the cells. General considerations are listed for each concept in this
section. In Section 2.3, the concepts are compared against both system-level and
oxygenator-specific requirements .
2.2.1 Oxygen Permeable Membrane
Many oxygenation methods for closed systems use permeation of oxygen through
a membrane interface that contains the fluid and separates it from an external en-
vironment. The membrane can be flat, with shallow channels guiding fluid against
it, or tubular, with fluid either inside or outside the tube. Extracorporeal membrane
oxygenation (ECMO) and existing microfluidic devices [10, 11, 20] offer inspiration
for possible configurations.
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Cross-membrane and free-surface oxygenation approaches are limited by the effec-
tive diffusion distance and by the surface area of the interface. Membrane oxygenation
is additionally limited by the rate of oxygen permeation through the membrane ma-
terial, which must be biologically inert, non-sorptive of a wide range of drugs and
biomarkers, non-permeable to liquid, and highly permeable to oxygen. One such ma-
terial that has been used in cell culture applications is DuPont Teflon AF-2400 [17],
but at a cost of approximately $30,000 per kg for raw material (quoted June, 2017 by
Biogeneral, San Diego, CA) plus tooling costs. Alternatively, using a polyurethane
membrane currently in the platforms developed by the Griffith Lab [2, 6] offers an
opportunity to reduce cost and complexity, but the thickness required for pumping
and sealing leads to very slow permeation. Pressurized air or pure oxygen could ac-
celerate oxygen permeation across a membrane, but introduces other setup and safety
concerns.
2.2.2 Interior Corner
The interior corner concept (Figure 2-1) makes use of the tendency of a wetting
fluid to pin to interior corners. In the LiverChip, where the oxygenator is simply a
wide, open channel, if the fluid height is decreased past a certain threshold, the fluid
clings to the corners, dramatically reducing the surface area available for oxygena-
tion, and creating unpredictable performance. This concept takes advantage of this
phenomenon to constrain the fluid in a predictable geometry, so that the oxygenator
length can be designed deterministically to meet the system needs. One additional
requirement for predictable geometry is the downward slope of the flow path: the neg-
ative pressure pulls the fluid tightly into the corner, rather than expanding arbitrarily
outward.
The interior corner was originally conceived as a grooved switchback path carved
into a downward sloping ramp, but the fluid behavior at the switchbacks is difficult
to predict, and was thought to be less robust than the corner path itself. A spiral
ramp (Figure 2-2) resolves this issue, allowing a long, continuous corner to fit in a
more contained footprint.
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Figure 2-1: A) As fluid wets an inside corner of a hydrophillic surface, surface tension
thins the fluid into a curved profile, both limiting diffusion distance ℎ and constrain-
ing the fluid path. B) A radius on the internal corner can reduce the effective diffusion
length even further. C) If the material is not sufficiently hydrophillic to fill sponta-
neously, a groove causing spontaneous capillary flow can aid rapid wetting of the full
surface. D) The corner can be cut into a downward sloping surface, ensuring that the
oxygenator is self-emptying. For compact packaging, the path may need to double
back on itself with some sort of switchback, but it is difficult to manage flow at the
switchback corner.
The aim in making an efficient oxygenator is to decrease the diffusion path rela-
tive to the interface area. The diffusion length scale can be further reduced in this
configuration by introducing a corner radius that is smaller than the fluid interface
radius.
Spontaneous capillary flow (SCF), if not achieved by the contact angle and corner
geometry alone, can potentially be achieved through a narrow triangular groove such
that the groove half-angle and the fluid contact angle sum to less than 90 degrees
[21]. As an alternative, the conditions for an SCF channel are described by Berthier
et al. [22].
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Figure 2-2: To avoid the potential instabilities associated with switchbacks, the in-
terior corner can be packaged in a spiral. A) An exterior spiral maintains fluid
continuity, and a pressure drop from top to bottom keeps the fluid profile tight in the
corner. B) The exterior spiral can be elongated to improve packaging. C) An interior
spiral is an alternate configuration, though there may be a tendency for fluid to pool
at the bottom.
2.2.3 Exterior Corner
The phenomenon of a wetting fluid being contained by a sharp edge [23] can be
used to create a fluid path suitable for oxygenation, as shown in Figure 2-3. One
potential risk is spilling over the edge of the corner. This might be mitigated with an
inverted configuration, where the fluid is suspended from a sharp-edged protrusion.
In either case, this concept seemed less robust than others, and so was not pursued
in detailed designs.
2.2.4 Channel
The LiverChip uses a channel with a free surface to oxygenate the circulating
media, though with over two times the volume targeted for this project. Doing so
at lower volumes might be accomplished with a long, shallow channel (Figure 2-4).
However, there are several drawbacks. The channel cannot be much wider than the
capillary length (approximately 2.5 mm) or fluid will separate and cling to the corners.
Additionally, the height of fluid in the channel (and therefore diffusion length) is
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Figure 2-3: A) The exterior corner concept uses a sharp exterior edge to contain fluid
expansion and guide it along an oxygenation path. B) As with the interior corner, a
feature could be introduced to the flow path to reduce the effective diffusion length.
C) The concept could also be inverted, suspending the flow from a guiding path on
the lid.
difficult to define, especially if the fluid pins to the top edges of the channel. The
diffusion length is likely to be larger relative to the air contacting surface area than
for the interior or exterior corner, reducing the oxygenation effectiveness relative to
those concepts.
2.2.5 Filament
If fluid can be arranged to flow down a wetted filament (Figure 2-5, similar to
condensation running down the exterior of slanted pipes and eventually dripping at
a local minimum), the potential to spiral the filament may enable a more compact
design than other concepts. The filament could be formed into the desired geometry,
and either removed for sterilization or disposed of after each use. However, this
concept does require an additional component, marginally increasing cost, logistical
overhead, and setup time, similar to a membrane (though attachment could be much
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Figure 2-4: A) The channel concept uses a channel to guide the fluid flow. B) This
channel could be spiraled around the interior of a well. C) The channel could snake
back and forth down a ramp inclined anywhere from 0 degrees (flat) to 90 (vertical
wall) to 180 (suspended upside-down).
simpler than sealing a membrane, and priming the fluid path to ensure wetting could
be accomplished by dipping the apparatus in sterile BSA solution).
2.2.6 Gap-spanning
Similar to the filament concept, if two filaments are placed in closer together than
the capillary length the fluid paths may join to form a fluid bridge (Figure 2-6). This
would increase further the exposed interface area relative to the diffusion depth for
a given length of the oxygenator. The angle of each gap edge should be chosen with
the contact angle of culture medium on that material in mind so as to make a fluid
bridge energetically favorable, and thus make it form reliably.
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Figure 2-5: The filament concept, similar to the inverted exterior corner concept in
Figure 2-3-C, uses the suspension of fluid from a feature to constrain the fluid path
and provide oxygenation. The filament has the advangage of wrapping over itself in
a spiral (left), allowing for tighter packaging. The filament cross section (right) could
be round or angular.
h
Figure 2-6: The gap-spanning concept consists of two hydrophillic angled features
with a gap between them. When fluid bridges this gap, surface tension pulls it
into a tight profile (right). The maximum diffusion distance ℎ is further reduced by
symmetry, if the fluid is oxygenated from both sides (left).
2.2.7 Droplets
The diffusion length of oxygen through the culture media could be limited by form-
ing small droplets which then drip into a collector and feed back into the cell culture
well (Figure 2-7). To keep pace with the oxygen consumption of the hepatocytes, an
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Figure 2-7: The droplets concept relies on the short diffusion distance during the
initial formation of a droplet (left). The maxiumum diffusion distance over time will
be the droplet radius. To maintain small droplets while allowing reasonable flow
rates, an array of many droplet generating outlets could be used (right).
array of multiple sources might be required as shown in Figure 2-7-B. However, this
concept involves substantially more manufacturing and sterilization complexity than
the others.
2.2.8 Surface Modification
Figure 2-8: Fluid could concievably be constrained and guided by an interface between
hydrophillic surface treatment (red, under the fluid path) and hydrophobic surface
treatment (green).
A barrier between hydrophillic and hydrophobic regions by some method of surface
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modification could be used as a method of steering fluid in a long path (Figure 2-8).
This concept was not pursued due to concerns about robustness and the development
effort and compromises involved in the surface treatment. If appropriate surface
treatments are developed, perhaps to satisfy other requirements, this concept may
become compelling.
2.2.9 Successive Barriers
h
Figure 2-9: This concept uses successive barriers to thin out the fluid profile, reducing
diffusion distance at the barrier, while using intermediate reservoirs to stabilize the
flow, since a thin film longer than the capillary length ( 2-4 mm) will not be stable.
If the fluid could be limited to a very thin film in even just a few regions, the
overall oxygenation rate would increase. This might be accomplished by introducing
barriers between deeper segments, as shown in Figure 2-9. The barriers force a thin
film over a distance shorter than the fluid capillary length, while the deeper segments
provide stability to the overall flow path. One challenge might be reducing the volume
required by the intermediate deeper regions.
2.3 Concept Selection
The corner flow oxygenation concept was selected for implementation based on
the anticipated performance relative to the requirements and anticipated develop-
ment/manufacturing time as expressed in table 2.1. Integration into the platform
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itself with no crevices or interfaces requiring adhesive is a significant advantage for
sterilization, cell compatibility, and usability over most other concepts. Further, the
design is resistant to sloshing, and bubbles stay trapped at the top of the oxygenator
without being passed on to the cell culture well.
2.4 Prototyping
Designing an open-well system at very low volumes requires careful attention to
surface tension effects, which can be difficult to predict by modeling alone. The design
process relied heavily on quickly iterating prototypes and breadboard models to test
individual components of the system.
Two surrogates were used in the process: (1) a 1% bovine serum albumin (BSA)
solution in phosphate buffered saline (PBS) was used as a less-expensive substitute
for the cell culture medium, (2) and stereolithography (SLA) resin prototypes were
plasma-treated to approximate the wetting properties of polysulfone (PSU) [24]. Poly-
sulfone is highly inert, autoclavable, and minimally adsorbing of a wide range of drug
compounds. For these reasons, it has been used in previous Griffith Lab platforms
[2, 6] and was chosen as a suitable material for the top plate of the platform developed
for this project. However, it is expensive and time-consuming to fabricate PSU pro-
totypes, and SLA prototyping allowed much faster and less expensive development
and testing of protoypes.
To validate plasma-treated SLA as a surrogate prototyping material, an equal
volume of of BSA solution was pipetted onto the two surfaces and compared (Fig-
ure 2-10). Absent equipment for measuring contact angle accurately, comparing the
footprint of the two equal-volume droplets is a reasonable indication of how close the
contact angles are. The drop on the polysulfone appears larger, indicating that the
contact angle of 1% BSA solution on PSU is lower than that on plasma treated SLA,
but they are relatively close, and plasma-treated SLA should work as a prototyping
surrogate for observing surface tension effects.
The simple SLA breadboard model shown in Figure 2-11 is an initial tool to assess
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SLA Resin Polysulfone
Figure 2-10: To evaluate plasma treated SLA (Clear v2 Resin, Formlabs, Somerville,
MA) surface as an easily prototyped surrogate for machined polysulfone (PSU), an
equal volume of fluid was pipetted onto clean surfaces of plasma treated SLA (left)
and untreated PSU (right). The size of the drop is an indication of wetting, and
shows rough equivalence between the two surfaces.
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Table 2.1: Decision matrix for oxygenator concept selection. Relevant sections for each concept are cited in the headings.
Membrane oxygenation is taken as the standard, and the anticipated performance of each concept is ranked as much better
(++), better (+), the same (0), worse (-) or much worse (- -) than a membrane oxygenator against the functions and attributes
listed at left. The total scores for each concept indicate the appropriateness of pursuing each concept.
Mem-
brane
2.2.1
Internal
Corner
2.2.2
External
Corner
2.2.3
Channel
2.2.4
Filament
2.2.5
Gap
2.2.6
Droplet
2.2.7
Surface
Mod.
2.2.8
Barriers
2.2.9
Cell/drug compatibility 0 + + + 0 + 0 - +
Vol < 500 𝜇L 0 0 - - + 0 - - - -
Sterilization/usability 0 ++ ++ ++ 0 + - + ++
Fit with pneumatic infrastructure 0 0 0 0 0 0 - 0 0
𝜑 > 0.8 @ 1 𝜇L/s 0 + + 0 + + 0 + +
Bubble clearing 0 ++ ++ 0 ++ + 0 + +
Resume after 5 min 0 - - - - - - - 0 - - 0
Volume-limiting 0 - - - - - - - - - - - -
Manufacturing complexity 0 + + + 0 - - - +
Robustness 0 - - - - - - - 0 - - -
Cost 0 ++ ++ ++ + ++ + 0 ++
Development risk 0 + + + 0 - - - - 0
Total 0 +6 +3 +2 +3 0 -5 -8 +3
the scale and viability of flow in a corner as an oxygenator concept. It demonstrates
the desired wetting behavior, though not spontaneous capillary filament formation,
indicating the contact angle is greater than 45 degrees [21]. Once the channel is
wetted, fluid travels in the conduit formed by the corner and the free surface, as long
as fluid is being evacuated from the opposite end. If fluid enters one end without
being removed from the other, the free surface expands out away from the corner and
holds volume. If the inlet is elevated relative to the outlet by tilting the device, the
excess fluid accumulates in the exit well, and the free surface tightens into the corner,
due to the pressure drop 𝜌𝑔ℎ across the channel.
Figure 2-11: One of several preliminary SLA models to evaluate corner wetting be-
havior. Fluid is introduced through the tube on the left and sinks from the well on
the right. The SLA has been plasma treated. Fluid is 1% BSA in PBS with food dye
for better visibility.
One challenge involved with achieving adequate oxygenator length on a small plat-
form is how to change the flow-path direction to allow tight packaging. Switchbacks
were considered, but the additional exposed surfaces at the switchback corners can
allow fluid to spread into other undesired regions or or create fluid instabilities at the
corner. A spiral configuration resolves this challenge by maintaining an approximately
straight path if the curvature of the spiral is significantly larger than the curvature of
the fluid free surface. An interior spiral was evaluated, as shown in Figure 2-12), but
an exterior spiral was chosen for two primary reasons. First, with an interior spiral,
the cell culture well must sit within the bounds of the spiral, or a secondary collection
pool at the base of the spiral must be pumped into the well. It is thus difficult to
have passive emptying into the well. Second, if the interior curve is made too tight,
fluid pools at the corner as described by the Young-Laplace equation, increasing the
diffusion length. For an exterior corner, the path curvature at the corners is negative
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relative to the fluid interface curvature, and the Young-Laplace equation forces the
radius of curvature of the fluid free surface to become smaller, shortening the diffusion
length (see Figure 2-24 in Section 2.5 for elaboration on this phenomenon).
Figure 2-12: Interior spiral breadboard. Plasma treated SLA, flowing 1% BSA solu-
tion with food dye.
An exterior spiral breadboard is shown in Figure 2-13. Because there is a feature at
the bottom of the spiral that allows fluid to accumulate, the fluid profile is significantly
thicker at the base than at the top. This was resolved by including a wetted exit ramp
into the cell culture well that provides a continuous fluidic connection to a region at
a lower pressure head, thereby evacuating excess fluid from the oxygenator flow path
(Figure 2-14).
Once the fluid behaved as desired, the oxygenation potential of an exterior spiral
breadboard model was measured using probes (810 𝜇m needle probes, Lucid Scientific,
Atlanta, GA) placed at the inlet and outlet (Figure 2-14).
A polysulfone spiral (Figure 2-15) was also fabricated to validate plasma treated
SLA as a surrogate, and to present any issues caused by machining the spiral. The
oxygenator exit region was cut away to facilitate manufacturing and to enable the
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Figure 2-13: An early SLA (sterolithography) exterior spiral breadboard model. The
SLA has been plasma treated for 1 min to approximate the wetting properties of
polysulfone. Note the undesired accumulation at the exit caused by stable wetting in
the exit channel.
Figure 2-14: A later SLA exterior spiral breadboard with probes in position to mea-
sure oxygenation potential. Accumulation at the base of the spiral has been reduced
by including a wetted slope into the cell culture well to provide reliable exit flow.
fluid to spill out into a wide plate rather than backing up into the oxygenator. Data
presented later in Figure 2-28 show the similarity between SLA and PSU spiral per-
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formance, and validate plasma treated SLA as a surrogate prototyping material.
Figure 2-15: The first machined Polysulfone (PSU) spiral oxygenator, to compare
wetting behavior between PSU and plasma treated SLA. The corner channel has a
radius of 0.5 mm, as machined by the cutting tool.
The next oxygenator iteration, on the revision 1 platform (Figure 2-16), was
shorter in height than the previous spirals, in order to reduce the platform height
and the thickness of raw polysulfone stock needed for manufacture. This compressed
spiral showed an oxygenation potential similar to the taller PSU spiral (Figure 2-21).
For packing multiple replicates on a single platform, it is easiest to have the pump
geometry in the same position across all replicates, allowing the pneumatic channels
to run straight across the platform without crossing. This led to an elongated spiral
design, shown in Figure 2-17. This first SLA breadboard included narrow guidance
grooves around the oxygenator curves, intended to facilitate wetting upon initial
startup of the oxygenator. These grooves were ineffective (note the buildup of fluid
before the first curve in Figure 2-17), though we expect effective guidance channels
could be designed with some additional effort. Because the oxygenator can be primed
with BSA before operation, and the oxygenator cannot be stopped for longer than tens
of seconds, such spontaneous capillary flow channels are not necessary for function,
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Figure 2-16: The Revision 1 spiral oxygenator, which is shorter than the original PSU
spiral. The geometry of the well and the flow tests using this prototype are discussed
in Chapter 3
and this development was left for future iterations.
After further SLA validation of the wetting characteristics of an elongated spiral
oxygenator without guidance channels, the revision 2 platform was machined from
polysulfone (Figure 2-18). This oxygenator was half the height of Rev 1, and one
fourth the height of the PSU spiral breadboard. Each lane is surrounded by a barrier
to prevent cross-contamination. The flat surfaces are sloped so as to empty to the
end of the oxygenator, and the radius at the base of the barrier walls is large enough
to prevent fluid accumulation.
2.5 Oxygenator Diffusion Model
This section describes analytic modeling that aims to predict oxygenator perfor-
mance and highlight its dependence on various physical parameters. The model is
compared to measured data, and simple approximations offer both a sanity check and
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Figure 2-17: The spiral was adapted to an elongated format to facilitate packing
replicate loops on the same platform. This SLA model also includes small grooves
around the curves intended to facilitate wetting, but which instead seemed to prevent
effective emptying (red arrow). Note the fluid has backed up at the curve, preventing
the corner from filling down-stream.
Figure 2-18: The revision 2 oxygenator. The spiral oxygenator is elongated to facili-
tate packing multiple replicates on the platform, and is half the height. to reduce the
cost of the raw polysulfone stock needed to machine the platform.
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an order-of-magnitude guide for future designs.
The performance of the oxygenator can be described by an efficiency that Inman
[3] calls 𝜑, the oxygenation potential:
𝜑 ≡ 𝐶𝑏 − 𝐶𝑎
𝐶𝑠𝑎𝑡 − 𝐶𝑎 , (2.2)
where the oxygen concentration difference of inlet (𝐶𝑎) and outlet (𝐶𝑏) is normalized
by the maximum possible oxygenation, that is when the outlet is at saturation 𝐶𝑠𝑎𝑡.
This parameter allows comparison of oxygenators across experiments, where the input
concentration is likely to vary, and is independent of cell oxygen consumption activity.
Further, it can be directly measured with a probe each at the oxygenator inlet and
outlet.
h
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Figure 2-19: Plug flow model used for simplified oxygenator modeling.
The analysis that follows expresses this oxygenation potential in terms of relevant
parameters of the system: flow rate 𝑄, diffusion depth ℎ, air-liquid interface area 𝐴,
and the diffusion coefficient 𝐷𝑂2 . We assume plug flow, which requires that (1) there
is no diffusion in the direction of advection, i.e. down the length of the oxygenator
channel and also that (2) the velocity field is uniform. We can check the validity of the
first assumption by estimating the Péclet number, Pe, which compares the advective
transport rate to the diffusive transport rate in the direction of advection [25]. The
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Péclet number is often expressed as
Pe𝐿 ≡ adv. ratediff. rate =
𝐿𝑈
𝐷
(2.3)
where 𝑈 is a characteristic velocity, 𝐿 is a characteristic length, and 𝐷 is a diffusion
coefficent. For the oxygenator we estimate its value using order-of-magnitude values:
the characteristic velocity is the flow rate 𝑄 ≈ 1 𝜇L/s divided by the fluid cross
sectional area 𝐴𝑐𝑠 ≈ 1 mm2, 𝐿 ≈ 100 mm is the length of the oxygenator, and
𝐷𝑂2 = 3 × 10−3[mm
2
s ] is the diffusion coefficient for oxygen in water at 37 °C. The
Pećlet number is then
Pe𝐿 =
𝐿𝑄
𝐷𝑂2𝐴𝑐𝑠
≈ 104 (2.4)
which indicates that advective transfer dominates, and diffusion along the length of
the oxygenator is negligible.. Note that we later use a different Péclet number, Peℎ,
which addresses diffusion perpendicular to advection, while Pe𝐿 is only used here
to validate the plug flow assumption that diffusion in the direction of advection is
negligible.
We first consider the diffusion of oxygen into a plug of fluid over time through the
surface ∆𝐴 in Figure 2-19. Fick’s First Law [25] relates the transport rate of a species
across a boundary to the concentration gradient at the boundary. In one dimension,
this is expressed as
𝐽 = −𝐷𝑂2
𝑑𝐶
𝑑𝑥
(2.5)
where J is the mass flux across the surface in [mol/mm2s] and C is the concentration
in [mol/mm3]. Note that below we will use units of 𝜇M, equivalent to [𝜇mol/L]. At
that point, the units of concentration will be set by the boundary conditions and 𝜇M
is more convenient. Here, we use [mol/mm3] to match the relevant length dimensions.
To find total oxygen entering the plug volume, we need the oxygen flux at the air-
liquid interface. As a first approximation, we can linearize the concentration gradient
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increasing time
Gas Liquid Gas Liquid
h
Figure 2-20: Left) As oxygen diffuses through the air-liquid interface at 𝑥 = 0, the
concentration will decrease exponentially with x. Right) We approximate 𝑑𝐶
𝑑𝑥
|𝑥=0 by
linearizing the concentration gradient between 𝑥 = 0 and 𝑥 = ℎ.
as shown in Figure 2-20. The oxygen flux at the surface is
𝐽 |𝑥=0 = −𝐷𝑂2
𝑑𝐶
𝑑𝑥
|𝑥=0 ≈ −𝐷𝑂2
𝐶ℎ − 𝐶𝑠𝑎𝑡
ℎ
(2.6)
where 𝐶ℎ is the oxygen concentration at the wall (𝑥 = ℎ) of the oxygenator opposite
the gas-liquid interface (𝑥 = 0), and the flux is in the direction of decreasing con-
centration. The linear concentration gradient that we assume means that the oxygen
transport rate at the interface is the same as at the wall, and can be written
𝐽 =
?˙?
∆𝐴
(2.7)
where ?˙? is the species transport rate in [mol/s] and ∆𝐴 is the area in [mm2] of the
gas-liquid interface for the individual plug. We define a mean concentration 𝐶𝑚 as
the quantity of species 𝑛 [mol] in the system divided by the volume 𝑉 [mm3]:
𝐶𝑚 =
𝑛
𝑉
=
2𝑛
∆𝐴ℎ
⇒ 𝐽 = ?˙?
∆𝐴
=
ℎ
2
𝑑𝐶𝑚
𝑑𝑡
. (2.8)
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Note that with a linear concentration gradient,
𝐶𝑚 =
𝐶ℎ + 𝐶𝑠𝑎𝑡
2
⇒ 𝐶ℎ = 2𝐶𝑚 − 𝐶𝑠𝑎𝑡. (2.9)
Using J in (2.8) and substituting 2.9 into (2.6), we obtain
ℎ
2
𝑑𝐶𝑚
𝑑𝑡
≈ −𝐷𝑂2
𝐶ℎ − 𝐶𝑠𝑎𝑡
ℎ
− ℎ
2
2𝐷𝑂2
𝑑𝐶𝑚
𝑑𝑡
= (2𝐶𝑚 − 𝐶𝑠𝑎𝑡)− 𝐶𝑠𝑎𝑡
𝑑𝐶𝑚
𝑑𝑡
+
4𝐷𝑂2
ℎ2
𝐶𝑚 ≈ 2𝐷𝑂2
ℎ2
𝐶𝑠𝑎𝑡. (2.10)
Solving the differential equation in (2.10), we obtain
𝐶𝑚 ≈ 𝐴1𝑒−
𝑡
𝜏𝐷 + 𝐴2 (2.11)
where 𝐴1 and 𝐴2 are constants and 𝜏𝐷 = ℎ
2
4𝐷𝑂2
is the time constant of diffusion.
Applying the boundary conditions 𝐶𝑚 = 𝐶𝑜 at 𝑡 = 0 and 𝐶𝑚 = 𝐶𝑠𝑎𝑡 as 𝑡→∞ gives
𝐶𝑚 ≈ (𝐶𝑜 − 𝐶𝑠𝑎𝑡)𝑒−
𝑡
𝜏𝐷 + 𝐶𝑠𝑎𝑡. (2.12)
Rearranging,
𝐶𝑚 ≈ −(𝐶𝑠𝑎𝑡 − 𝐶𝑜)𝑒−
𝑡
𝜏𝐷 + (𝐶𝑠𝑎𝑡 − 𝐶𝑜) + 𝐶𝑜
(𝐶𝑚 − 𝐶𝑜) ≈ (𝐶𝑠𝑎𝑡 − 𝐶𝑜)(1− 𝑒−
𝑡
𝜏𝐷 )
(𝐶𝑚 − 𝐶𝑜)
(𝐶𝑠𝑎𝑡 − 𝐶𝑜) ≈ (1− 𝑒
− 𝑡
𝜏𝐷 ). (2.13)
Equation 2.13 describes the time evolution of the mean concentration of a single
plug. If this plug enters the oxygenator at an initial mean concentration 𝐶𝑜 = 𝐶𝑖𝑛,
it will exit at 𝐶𝑚 = 𝐶𝑜𝑢𝑡 after a residence time 𝑡 = 𝜏𝑎 = 𝐿𝑈 . At the exit of the
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oxygenator,
𝑡
𝜏𝐷
=
𝜏𝑎
𝜏𝐷
. (2.14)
Recalling the definition of the oxygenation potential (equation 2.2), and using 2.14,
equation 2.13 becomes:
𝜑 ≡ 𝐶𝑜𝑢𝑡 − 𝐶𝑖𝑛
𝐶𝑠𝑎𝑡 − 𝐶𝑖𝑛 ≈ (1− 𝑒
− 𝜏𝑎
𝜏𝐷 ). (2.15)
The residence time 𝜏𝑎 can be estimated by referring to Figure 2-19. For a triangular
oxygenator,
𝐴 = 𝐿𝑤 (2.16)
𝐴𝑐𝑠 =
1
2
ℎ𝑤 =
ℎ𝐴
2𝐿
(2.17)
𝑈 =
𝑄
𝐴𝑐𝑠
=
2𝐿𝑄
𝐴ℎ
(2.18)
⇒ 𝜏𝑎 = 𝐿
𝑈
=
ℎ𝐴
2𝑄
. (2.19)
To relate this residence time 𝜏𝑎 to the diffusion time constant 𝜏𝐷 we use a Pé-
clet number Peℎ, which refers to the rate of diffusion orthogonal to the direction of
advection to a depth h (while Pe𝐿 used above refers to diffusion in the direction of
advection to a length L). This Peℎ captures how much or how little diffusion can
occur in the time that the fluid plug travels through the oxygenator, and depends on
the flow rate 𝑄, system geometry as represented by ℎ
𝐴
, and diffusion coefficient 𝐷𝑂2 :
Peℎ =
adv. rate
diff. rate
=
1/𝜏𝑎
1/𝜏𝐷
=
𝜏𝐷
𝜏𝑎
=
𝑄ℎ
2𝐷𝑂2𝐴
. (2.20)
The flow rate is on the order of 1 𝜇L/s, and the lengths are on the order of 1 mm. Note
that for a rectangular oxygenator with 𝐴𝑐𝑠 = ℎ𝑤 and 𝐴 = 𝑤𝐿, the Péclet number is
also 𝑄ℎ
2𝐷𝑂2𝐴
.
Substituting this modified Péclet number into equation 2.15 gives an expression
53
for the oxygenator efficiency in terms of the geometry and flow rate of the fluid path:
𝜑 =
𝐶𝑜𝑢𝑡 − 𝐶𝑖𝑛
𝐶𝑠𝑎𝑡 − 𝐶𝑖𝑛 ≈ (1− 𝑒
− 1Peℎ ) (2.21)
Figure 2-21 shows predictions of the oxygenator efficiency 𝜑 for arbitrary ℎ
𝐴
next to
measured 𝜑 values from the LiverChip, an intermediate prototype, and the final revi-
sion 2 prototype. Note that equation 2.21 shows that 𝜑 is a concentration-independent
characterization of oxygenator performance and depends only on system geometry,
oxygenator flow rate, and the diffusion coefficient.
1 2 3 4 5 6 7 8 9 10
Oxygenator Flow Rate [ L/s]
0.0
0.2
0.4
0.6
0.8
1.0
Predicted Oxygenation Potential
h/A = 0.0005
h/A = 0.001
h/A = 0.002
h/A = 0.004
Measured: PSU Spiral
Pe Model: PSU Spiral
Measured: LiverChip
Measured: Rev1
Measured: Rev2
Figure 2-21: Oxygenation potential as a function of flow rate for various ℎ
𝐴
. Solid
lines represent the prediction of equation 2.21 for various geometries, represented by
ℎ
𝐴
. Experimental data are presented for the existing LiverChip, the reduced liver
prototypes revision 1 and 2, and an earlier oxygenator prototype (PSU_spiral). The
dotted blue line shows values calculated from (2.21), using measured values for ℎ
𝐴
as
described in Figure 2-22. The LiverChip data are from appendix C. The LiverChip
flow rate is limited to 2 𝜇L/s by the on-board pumps, so the LiverChip data are only
provided at 1 and 2 𝜇L/s.
Increasing either ℎ
𝐴
or𝑄 decreases 𝜑; the faster a fluid plug is moving, or the farther
the oxygen must diffuse into the system for a given surface area, the farther from 𝐶𝑠𝑎𝑡
the plug will be upon exiting. At these flow rates, the Revision 2 prototype matches
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LiverChip oxygenator performance, while the earlier breadboard (PSU_spiral) shows
better performance (at the cost of oxygenator height) for reasons discussed below.
To assess the oxygenation model empirically, we imaged the fluid profile under
flow (1-4 𝜇L/s) in the incubator (35-37 °C during measurements) using a Dyno-Lite
USB microscope (AnMo Electronics Corporation, TWN). The images were processed
using ImageJ software (https://imagej.nih.gov/ij/), as shown in Figure 2-22. Because
the profile varied with height, the ℎ
𝐴
values from position C were used in calculating
the PSU Spiral values in Figure 2-21.
A) B)
C) D)
Figure 2-22: The fluid profile in the oxygenator corner is imaged at the locations
labeled A through D in Figure 2-27 and measured using ImageJ software. A) In an
image used to measure the profile at location B at 1 𝜇L/s, a 1/16 in. drill bit in
the plane of the profile is used for scale. B) The measurement ℎ′ is taken from the
fluid surface to the corner obtained by extending the PSU edges, and then 0.2 mm
is subtracted to account for the corner radius and obtain ℎ. C) The value for 𝑤 is
measured two ways, first by a straight line. D) The value of 𝑤 is also found by tracing
the fluid interface with a freehand tool and measuring the path length. There is less
than a 10% difference between the two methods, and it seems to have little effect on
𝜑, but the free-hand method is used for all values presented here.
As shown in Figure 2-21, the model above over-estimates the oxygenation po-
tential. We believe this is partly due to the linearized concentration profile used to
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calculate the average concentration 𝐶𝑚. As shown in Figure 2-20 on the right, a linear
profile will always over-predict a mean concentration calculated by dividing the area
under the curve by h. As shown on the left, the error is particularly large early on in
the development of the profile, before the diffusion has reached the distance ℎ.
To describe 𝜑 in terms of a mean concentration that is integrated over the profile,
we can borrow a model described by Glicksman and Lienhard for heat transfer ap-
plications [26]. For diffusion into a bulk slab, we can use the first term of a Fourier
series to approximate the concentration profile. This model, described in detail in
Appendix B, relates the normalized mean temperature, or in this case concentration,
to the dimensionless Fourier number, which describes the ratio of diffusive transport
to storage rate. In mass transfer, for characteristic time 𝑡 and length ℎ,
Fo𝑚 =
𝐷𝑂2𝑡
ℎ2
. (2.22)
At the end of the oxygenator, 𝑡 = 𝜏𝑎. Thus, approximating the triangular geometry
as a slab of thickness ℎ/2 and using equation 2.19 yields
Fo𝑚 =
𝐷𝑂2
ℎ2
ℎ𝐴
2𝑄
=
𝐷𝐴
2𝑄ℎ
. (2.23)
Using tabulated coefficients for the slab geometry, we can express the oxygenation
potential as
𝜑 =
𝐶 − 𝐶𝑜
𝐶𝑠𝑎𝑡 − 𝐶𝑜 = 1− 0.8106𝑒
−2.47Fo𝑚 (2.24)
where 𝐶 is the spatially averaged concentration in 𝑥 from the free surface down to
𝑥 = ℎ.
This one-term approximation model, shown in Figure 2-23, better predicts the
measured oxygenation potential for the PSU spiral, when the changing ℎ
𝐴
values are
taken into account. The Rev2 data, however, appear even more divergent than in the
Péclet number model when ℎ
𝐴
is constant (compare to green line in Figure 2-21).
The remaining discrepancy between the one-term model and the measured values
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Oxygenator Flow Rate [ L/s]
0.0
0.2
0.4
0.6
0.8
1.0
One-Term Model
h/A = 0.0005
h/A = 0.001
h/A = 0.002
h/A = 0.004
Measured: PSU Spiral
Pe Model: PSU Spiral
1-term: PSU Spiral
Measured: LiverChip
Measured: Rev1
Measured: Rev2
Figure 2-23: The one-term approximation for oxygenation potential. The solid lines
are calculated from equation 2.24 for various ℎ
𝐴
values, and the 1-term result is calcu-
lated from the same model using measured dimensions from the PSU spiral at location
C, as shown in Figure 2-22. All other data are the same as in Figure 2-21.
for the PSU Spiral is small enough to be explained by lack of differences between
the true geometry and the approximated slab, the plug flow assumption of a uniform
velocity profile, or a combination of the two.
The measured values of 𝜑 for revision 2 decrease more with increasing flow rate
than either model predicts if ℎ
𝐴
is held constant. This is in contrast to the the models
based on the PSU spiral measured geometry, where 𝜑 was calculated using an ℎ
𝐴
value that was specifically measured for each flow rate. As the flow rate increases,
the cross sectional area, the radius of curvature, or both must increase to compensate
for the higher flow rate. This can be illustrated by combining the Young-Laplace
and Bernoulli equations, where the two reference points for the Bernoulli equation
are taken one at the top of the oxygenation spiral and the other in the fluid well
where the pressure is atmospheric and the velocity is negligible. The Young-Laplace
equation can be further simplified by assuming a straight path, where the radius
of curvature in the top plate 𝑅𝑥 → inf. Expressing the velocity as 𝑄𝐴𝑐𝑠 then gives
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equation 2.27 (note that 𝐴𝑐𝑠 is a function of 𝑅𝑦 and the fluid path width):
∆𝑃 = 𝛾
(︂
1
𝑅𝑥
+
1
𝑅𝑦
)︂
Young-Laplace Eqn. (2.25)
(𝑃1 − 𝑃2) + 𝜌
2
(𝑣21 − 𝑣22) + 𝜌𝑔(ℎ1 − ℎ2) = 0 Bernoulli Eqn. (2.26)
− 𝛾
𝑅𝑦
+
𝜌
2
𝑄2
𝐴2𝑐𝑠
+ 𝜌𝑔∆ℎ = 0 (2.27)
where ∆𝑃 is the pressure difference in [Pa] between the two sides of the interface, 𝛾
is the surface tension of the interface in [N/m], and 𝑅𝑥 and 𝑅𝑦 are orthogonal radii of
curvature of the surface (see Figure 2-24). In 2.26, 𝜌 is the fluid density in [kg/m3],
and 𝑔 = 9.8[m/s𝑠]; 𝑃1,2 are the pressures in [Pa], 𝑣1,2 are the average fluid velocities
in [m/s], and ℎ1,2 are the heights in [m] at points one and two in the system.
Rx
Ry
Figure 2-24: An illustration of the radii of curvature of the fluid surface. In this case,
𝑅𝑦 is positive and 𝑅𝑥 is negative
In practice, the free surface is observed to flatten out at higher flow rates, with a
slight increase in the fluid path width until it is limited by the oxygenator edge. As
the free surface changes from concave to flat, exposed surface area is decreasing as the
diffusion length is increasing, so ℎ
𝐴
must increase. This would result in a decreased
𝜑 as the flow rate increases. This is supported empirically when there is a negative
pressure on the fluid from the 𝜌𝑔ℎ height difference, as shown in Figure 2-25.
Figure 2-21 also shows measurements from the revision 1 spiral. These mea-
surements show a significantly higher oxygenation potential than those of revision 2,
though the oxygenator length was similar. Two effects can explain this: a fluid path
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Figure 2-25: The measured geometric ratio ℎ/𝐴 generally increased with increasing
flowrate, as predicted. The effect was significant at a greater height (position A),
while negligible closer to the base of the spiral (position D). Also note that h/A is
generally smaller at the higher position, confirming that spiral height plays an indirect
role in oxygenation potential 𝜑. These measurements were taken from the PSU spiral,
as shown in Figure 2-22.
curved in the top plate and a greater height difference. A convex curved path, by
equation 2.25, requires a more concave curvature in the fluid profile. This tightens
the fluid path against the corner, decreasing ℎ
𝐴
and therefore increasing oxygenation
potential relative to a straight path. The greater height difference has a similar effect
in decreasing the radius of curvature, a relationship described by equation 2.27.
We can estimate the relative contribution of these effects. Comparing two cases
with an equal pressure differential at the interface yields
1
𝑅𝑥
+
1
𝑅𝑦
=
1
𝑅′𝑥
+
1
𝑅′𝑦
(2.28)
𝑅′𝑦
𝑅𝑦
= 1 +
𝑅′𝑦
𝑅′𝑥
− 𝑅
′
𝑦
𝑅𝑥
. (2.29)
Let 𝑅′𝑦 ≈ 1 mm be the radius of curvature of the fluid profile in the cross sectional
plane for a corner-channel that has a radius in the top plane of 𝑅′𝑥 ≈ −10 mm (where
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curvature is positive if the center is on the air side of the interface, and negative if
the center is on the fluid side: see Figure 2-24). If we compare to a straight-path
oxygenator (𝑅𝑥 → inf), 𝑅
′
𝑦
𝑅𝑦
≈ 0.9; we expect at most a 10% change from this curvature
effect.
To assess the effect of height, we can rearrange equation 2.27 and compare between
two cases, assuming the cross-sectional area stays constant:
𝑅′𝑦 −𝑅𝑦 =
𝛾
𝜌𝑔
(︂
1
∆ℎ′
− 1
∆ℎ
)︂
approximating
∆ℎ′ = 2∆ℎ ≈ 0.01 m
𝑅𝑦 ≈ 0.001 m
𝜌 ≈ 1000 kg/m3
𝑔 ≈ 9.8 m/s2
𝛾 ≈ 0.06 N/m [27]
gives
𝑅′𝑦
𝑅𝑦
= 1− 𝛾
2𝜌𝑔∆ℎ𝑅𝑦
≈ 0.4.
This indicates that between the two measured oxygenators, the difference in oxygena-
tion potential derives primarily from the height difference, and the curvature effect is
relatively minor.
2.6 Testing and Performance
To measure the oxygenation potential, deoxygenated BSA solution is flowed through
the oxygenator, and the dissolved oxygen concentration is measured at the inlet and
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outlet. The oxygenation potential, f , is then calculated using equation 2.2. 1%
Bovine serum albumin (BSA) in phosphate-buffered saline (PBS) is deoxygenated by
bubbling nitrogen in a glass container. The media is then pumped through PEEK
tubing (1/16 in. OD, 1/32 in. ID) with a pneumatic membrane pump. For subse-
quent tests, at flow rates higher than 2 𝜇L/s, deoxygenated BSA solution is extracted
from the bubbler with a syringe and flow is controlled using a syringe pump, as the
pump block cannot supply these higher flows. Because the oxygenation potential is
concentration-independent, the media does not have to be completely deoxygenated
at the inlet. Probes were positioned so as to fully immerse the tip in the fluid path.
The setup is allowed to sit in the incubator at 37 degrees C for at least 30 minutes
to bring the platform to temperature. The media had sat in the incubator for 1-2
additional hours to deoxygenate and come to temperature. The setup used for the
SLA spiral is shown in Figure 2-26.
Figure 2-26: Setup for measuring oxygenation potential in an incubator at 37 Celsius.
A solution of 1% Bovine Serum Albumin in PBS is deoxygenated at left by bubbling
nitrogen. The BSA is then pumped through a pump block and to the top of the
spiral, where probes at top and bottom measure the dissolved oxygen concentration
difference.
A simple plug flow model predicts that as the oxygenator length increases for a
constant flow rate, the outlet concentration will approach saturation with a decaying
exponential as a function of length (see Section 2.5, equation 2.21). This was exper-
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imentally assessed by probing the oxygen concentration at various locations on the
spiral, as shown in Figure 2-27.
D 
C 
B 
A 
F E 
Inlet
Figure 2-27: To assess the oxygenation potential at different oxygenator lengths, the
downstream probe was sequentially placed at the locations shown. Lengths from
inlet: A = 5.5 mm; B = 34.5; C = 75.2; D = 127.6; E = 177.5.
50 100 150 200 250
Oxygenator Length [mm]
0.0
0.2
0.4
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0.8
1.0 Oxygenation Potential vs. Length Measured: SLA spiral
Measured: PSU spiral
=(1-exp(-0.01318*L))
=(1-exp(-0.01084*L))
Pe Model
Figure 2-28: Oxygenation potential measured at various distances from the oxygena-
tor inlet of the SLA and PSU spiral breadboards, as shown in Figure 2-27. Flow rate
is 1 𝜇L/s. Exponential fit parameters 𝑘 are from a linear fit of ln(1−𝜑) = −𝑘𝐿. The
Peclet Model (2.21) uses the values of 𝑤 = 1.5 and ℎ = 0.2 measured for position C
at 1 𝜇L/s as described in figure 2-22.
62
The resulting data do show a decaying exponential approach to full oxygenation
as the length increases. Between the polysulfone and SLA materials, the difference
is minor. The Peclet model uses 𝑤 = 1.5 and ℎ = 0.2 measured for position C (see
figure 2-22). Substituting these values into equation 2.21 yields
𝜑 ≈ 1− 𝑒−0.045𝐿 (2.30)
The model over-predicts the oxygenation potential as described in Section 2.5.
Figure 2-29: The revision 2 spiral being fed externally through a PEEK inlet tube.
The inlet source was subsequently changed to a cannula entering from the bottom,
but the probe position remained the same. The probes and tubes pass through holes
drilled in the clear polystyrene lid.
To test the oxygenation potential of the revision 2 oxygenator, deoxygenated me-
dia is first fed from above through PEEK tubing. This setup resulted in dramatic
fluctuations in the probe readings due to bubbles at the top of the oxygenator. To
resolve this issue, a 1 mm OD stainless steel canula is inserted in the oxygenator inlet
hole from the bottom and fixed in place with a cyanoacrylate adhesive that loosens
with isopropyl alcohol (Loctite 4851, Henkel, DEU). Deoxygenated media is flowed
through the oxygenator using a syringe pump (Pump 11 Pico Plus Elite, Harvard
Apparatus, Holliston, MA). The dissolved oxygen concentration is measured at inlet
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and outlet (Figure 2-29). The oxygenation potential data are presented in Figure
2-21. The revision 2 shows an oxygenation potential similar to the LiverChip at low
flow rates, but considerably lower than the earlier breadboards. This may be due
to the smaller ∆ℎ (4 mm for revision 2, 8 mm for revision 1, and 16 mm for ear-
lier breadboards). Integration of the breadboards with the other components of the
platform is discussed in Chapter 3.
Figure 2-30: A 1 mm OD stainless steel cannula is inserted into the oxygenator inlet
from the bottom. The cannula is adhered to a segment of PEEK tubing which is
connected to flexible 0.01 in. ID PTFE tubing to prevent stress on the cannula.
The volume captured during flow is challenging to measure directly. 50 𝜇L pipet-
ted onto a spiral that had been primed with BSA and then dried appeared qualita-
tively to produce a profile similar to that seen at 2 𝜇L/s, but this is a rough estimate.
When flow at 2 𝜇L/s was suddenly stopped and the fluid immediately aspirated with
a pipette tip and massed, a maximum of 12 mg were recovered (12 𝜇L). Neither
of these values are difinitive, but lacking a better way of measuring the oxygenator
volume while it is pumping, they serve as an estimated range. The LiverChip, for
comparison, has an estimated oxygenator volume of 400 𝜇L (1.2 mL total volume,
less 50 𝜇L for the retaining ring and scaffold, less 750 𝜇L in the MPS and channels,
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shown in Figure 2-31).
Figure 2-31: The volume shown, 750 𝜇L, was used as part of the estimate of the
LiverChip oxygenator volume.
2.7 Summary
In this chapter, we present a wide array of free-surface oxygenator concepts, in
addition to a standard membrane approach. Of these, the spiral corner flow oxy-
genator has the advantages of being robust to disturbances, self clearing, and simple
to fabricate as part of the platform itself, improving ease and quality of steriliza-
tion. We validated SLA breadboards to develop this concept into an elongated spiral
oxygenator that performs equivalently to the oxygenation channel on the CN Bio
LiverChip.
A tighter radius on the fluid free surface yields better oxygenation. How tightly the
fluid clings to corner depends on surface and fluid wetting properties, path curvature
(spiral versus straight path), and pressure drop from top to bottom which is height
dependent. The taller spirals show better oxygenator performance, but we have
not developed analytically the relationship between the fluid surface radius and the
oxygenation. This modeling, in concert with testing, might provide guidance as to
how sensitive the configuration is to changes in height, and what the right balance is
between performance and additional material cost.
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Chapter 3
Media Circulation Layout
This chapter addresses the circulation system of the platform, which integrates
the oxygenator discussed in Chapter 2 with the microphysiological system (MPS)
that contains the cells. First, the requirements are described in Section 3.1. Con-
cepts are described in Sections 3.2 and 3.3. Analytic models of inline and mixed flow
are discussed and compared in Sections 3.4 through 3.6. Finally, data presented in
Section 3.7 suggest that the chosen configuration behaves like an inline system at low
flowrates, and will meet all requirements when flowing up through the scaffold, but
may not meet the 150 𝜇M concentration requirement when flowing down. Experi-
ments with the revision 2 platforms are still required to determine if this prediction
is accurate, and if so, the significance of not reaching 150 𝜇M before flow reversal.
3.1 Circulation Requirements
The fluid channel and pump arrangement will ultimately determine the oxygen
concentration of the media that is delivered to the cells. The following requirements
guided the concept selection and design process.
1. Re-circulation flow through scaffold must be reversible
When grown on the standard polystyrene scaffold, cells are "seeded" dur-
ing the first 8 hours, in which media flows down through the scaffold.
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In this flow direction, the filter prevents cells from passing through, and
they bind to the scaffold. After 8 hours, the flow is reversed and flows up
to prevent further accumulation of cells from clogging the scaffold chan-
nels, and this upward flow continues for the duration of the experiment.
2. Device must circulate media at 150 𝜇M O2 or greater, with flow
through the scaffold at 1 𝜇L/s (MPS flow rate)
This requirement assumes 250k rat hepatocytes or 600k human hepato-
cytes, with an expected oxygen consumption rate of approximately 100
pmol/s. 150 𝜇M is a target minimum, but the range of acceptable values
is not clearly defined. Blood oxygen concentration is approximately 150
𝜇M in the arteries and closer to 65 𝜇M in the portal vein, which feeds
into the liver [28]. However, because hemoglobin is storing additional
oxygen in the blood, cell culture medium must be at higher concentra-
tions than these to deliver the same total amount of oxygen. The flow
rate through the scaffold, 1 𝜇L/s, is chosen to match that used on the
LiverChip.
3. Each pump should be coupled across replicates
The existing pneumatic architecture controls one pumping degree of free-
dom (DOF) with three pressure/vacuum tubes (controlling one pump
chamber and two valves). To reduce complexity of the set-up, each
pump function (e.g. re-circulation, oxygenation, or media exchange)
that is consistent across replicates should be controlled by a single pneu-
matic DOF, which consists of one three-tube cluster. For experiments
to compare different flow rates, the flow rate can be varied over time, or
multiple platforms can be used; in any case a minimum of 6 replicates
would be desired for a single experimental case, justifying parallel flow
rates across replicates in a single chip.
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3.2 Circulation Concepts
The flow circulation configuration should meet the above requirements without
increasing the circulating volume beyond 500 𝜇L, and should allow relatively simple
fabrication and assembly.
3.2.1 In-line
The inline configuration (Figure 3-1) is the simplest, and is used on the existing
LiverChip platform (Figure 3-2). The media flows in a single loop, with the cells
consuming oxygen and the oxyenator replenishing it. The oxygenator flow rate is
therefore the same as the cell perfusion flow rate. Because the cell culture protocol
requires reversing flow after the first 8 hours, the oxygenator needs to function in
both directions, which precludes the use of of a down-hill self-clearing oxygenator. An
active flow path switching mechanism could allow use of a one-direction oxygenator,
but introduces additional complexity and circulating volume.
Cell Scaﬀold
MPS
Oxygenator
Pump
Downward Flow Upward Flow
High
Low
Oxygenation:
Figure 3-1: Inline Configuration: the oxygenator is on the same flow circuit as the
MPS and cell scaffold. The flow is downward (left) for the first 8 hours to help the
cells seed on the scaffold. After 8 hours, the flow reverses (right). This configuration
requires a reversible oxygenator.
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MPS
Oxygenator
Pump
Cell Scaﬀold
Figure 3-2: Inline Circulation on the CN Bio LiverChip during downward flow. The
oxygenator consists of a wide channel with enough exposed surface area to oxygenate
the media as it travels back to the MPS.
3.2.2 Co-flow
The co-flow configuration (Figure 3-3) decouples the oxygenator from the MPS
recirculation flow circuit. This allows a uni-directional oxygenator. When flowing
downward, if the flow rates are equal, the system behaves like an inline system,
and the cells are exposed to the highest saturation media in the system. However,
when flow is upward, the cells are exposed to a mix of oxygenated media from the
oxygenator and deoxygenated media from the MPS outlet. This results in the cells
being exposed to a lower oxygen concentration for a given oxygenator efficiency than
in an inline system.
3.2.3 Counter-flow
The counter-flow configuration (Figure 3-4) is similar to co-flow, but the cells are
exposed to the high-concentration media during upward flow, rather than downward
flow. This is advantageous, since exposure to the lower concentration mixed media
is limited to the first 8 hours of a multi-day experiment. Like co-flow, counter-flow
allows a unidirectional oxygenator. However, if the oxygenator flows downhill and is
not a closed system capable of suction, the pump must come before the oxygenator.
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Q1 Q2 Q1 Q2
Figure 3-3: Co-Flow: Left: During seeding, mixed oxygen concentration media enters
the oxygenator, and high oxygenconcentration media is fed to the cells. The small
flow down the central channel assumes 𝑄2 is only slightly greater than 𝑄1. Right:
After seeding, mixed media is fed to cells and to the oxygenator. 𝑄2 is in the same
direction in both flow conditions, so a unidirectional oxygenator can be used.
This makes fabrication more challenging than for the Co-Flow configuration, and
multiple vertical channels are needed to bring the pumps into the same plane. If
these channels are open, very slight differences in pump flow rates can lead to fluid
accumulation or depletion over time.
Downward Flow Upward Flow
Q1
Q2
Q1
Q2
Figure 3-4: Counter-Flow: Left: During seeding, mixed concentration media enters
the cells and oxygenator Right: After seeding, high concentration media is fed to cells
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3.2.4 Laminar Figure-8
What we call the figure-8 configuration (Figure 3-5) attempts to combine the
strengths of the co- and counter-flow concepts, so that the cells are exposed to high-
concentration media, but the oxygenator does not need to be reversible. During
downward flow, the system behaves like an inline system if the oxygenator and re-
circulation flow rates are the same, feeding high concentration media to the cells.
During upward flow, the short laminar section attempts to limit mixing, separating
the flow paths into a high concentration stream for the cells and a low concentration
stream for the oxygenator. The main drawback of this concept is its difficulty to
manufacture, and the potential requirement for additional volume compared to the
other systems.
2 1
3
4
2 1
34
2 1
34
Downward Flow Upward Flow
Figure 3-5: Laminar Figure-8: A laminar flow channel allows fluid paths of high and
low concentration to flow side-by-side only mixing by diffusion. At the bottom of
the channel, a wedge splits the flow, allowing the high and low concentrations to be
directed to the cells and the oxygenator, respectively. During downward flow, the
flow coming from the cells flows primarily around the flow splitter (1 to 2), through
the oxygenator (2 to 3), and into the cells (3 to 4), with flow from 3 to 2 if the
oxygenator flow rate is higher than the cell perfusion flow rate. During upward flow,
media comes up through the cells (1 to 4), primarily down the left side of the laminar
channel (4 to 2), through the oxygenator (2 to 3), and primarily down the right side
of they laminar channel (3 to 1).
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3.2.5 Selective Sourcing
The selective sourcing configuration (Figures 3-6 and 3-7) attempts to feed the
cells high concentration media during upward flow by placing the recirculation intake
directly under the oxygenator output. During downward flow, the cells see a mixed
concentration, but the oxygenator flowrate can be increased to increase oxygen trans-
fer to the system. Both pumps can be on the same plane below the MPS, and the
oxygenator can flow downhill to empty passively without reversing. Further, no ex-
tra reservoirs are required, making this configuration nearly as compact as the inline
system.
Downward Flow Upward Flow
1
2
3
4
1
2
3
4
Figure 3-6: Selective sourcing. During seeding (left), media flows down through the
cells, where oxygen is consumed, then from 1 to 2. A mixture of media from 3 (high
oxygen concentration) and 2 (low concentration) then flow both back through the
cells, and also to 4, which feeds the oxygenator. During upward flow (right), the cells
are fed by media sourced from 2, which is a mix of high concentration from 3 and low
concentration from the cells. The position of 2 directly under the oxygenator output
3 increases the ratio of high to low concentration media, so the cells see an oxygen
concentration above the bulk average in the well. At the input to the oxygenator (4),
the opposite occurs, pulling media that is below average oxygen concentration.
3.3 Circulation Concept Selection
The selective sourcing configuration was chosen as the best compromise between
feeding the cells high oxygen concentration and keeping fluid volume low and manu-
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Q1
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Spiral Oxygenator
MPS
Figure 3-7: Selective sourcing shown on the Rev2 platform during upward flow. 𝑄1
is the flow through the scaffold, and 𝑄2 is the oxygenator flow.
facturing straightforward. The inline concept feeds the cells the highest concentration,
but precluded the self-clearing oxygenators considered. The figure-8 configuration is
promising, but was deemed too complex a development effort for the scope of this
project.
3.4 In-Line Reactor Model
In the existing LiverChip platform, media flows in a single circuit through the
cell scaffold and along a long open well where the media is reoxygenated by passive
diffusion [3]. This can be understood with the simple model shown in Figure 3-8 (A).
In steady state, (𝐶ℎ𝑖𝑔ℎ−𝐶𝑙𝑜𝑤) = 𝑟𝑄 . Using the definition of the oxygenation potential
(eqn. 2.21), the steady-state concentrations in the system (where the subscript 𝑖
indicates the inline model) are
𝐶𝑙𝑜𝑤,𝑖 = 𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑖𝜑𝑖
(3.1)
𝐶ℎ𝑖𝑔ℎ,𝑖 = 𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑖𝜑𝑖
(1− 𝜑𝑖) (3.2)
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Figure 3-8: Schematic of (A) the inline and (B) the mixed reactor models. In A),
media leaving the oxygenator at 𝐶ℎ𝑖𝑔ℎ feeds directly into the cells and re-enters the
oxygenator at 𝐶𝑙𝑜𝑤 = 𝐶ℎ𝑖𝑔ℎ− 𝑟𝑄 . In (B) Media exits the oxygenator at a high oxygen
concentration 𝐶𝑜𝑢𝑡, mixes with bulk fluid volume to reach a mixed concentration 𝐶
and media at concentration 𝐶 then re-enters the oxygenator.
3.5 Mixed Reactor Model
During downward flow, and for sufficiently high oxygenator flow rates during up-
ward flow, we assume that the oxygenator is in a closed loop with a fully mixed
chamber at concentration C, which is steadily consuming oxygen at rate 𝑟. The in-
put to the oxygenator is therefore 𝐶, and the mass transfer into the oxygenator is
?˙?𝑂2 = 𝑄(𝐶𝑜𝑢𝑡 −𝐶𝑖𝑛), or ?˙?𝑂2 = 𝑄𝜑(𝐶𝑠𝑎𝑡 −𝐶), where 𝜑 is the oxygenation potential.
The rate of change of mass in the fully mixed system of volume 𝑉 is balanced by
the mass transfer into the oxygenator and the oxygen consumption by the cells:
𝑉
𝑑𝐶𝑚
𝑑𝑡
= ?˙?𝑂2 − 𝑟 = 𝑄𝑚𝜑𝑚(𝐶𝑠𝑎𝑡 − 𝐶𝑚)− 𝑟. (3.3)
Substituting for ?˙?𝑂2 and solving for concentration 𝐶:
𝐶𝑚 =
(︂
𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑚𝜑𝑚
)︂
(1− 𝑒−𝑄𝑚𝜑𝑚𝑉 𝑡). (3.4)
The steady-state (𝑡→∞) bulk concentration is therefore
𝐶𝑚(𝑡→∞) =
(︂
𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑚𝜑𝑚
)︂
(3.5)
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and the transient response time constant is 𝑉
𝑄𝑚𝜑𝑚
. Note that because this model
assumes a fixed oxygen consumption rate 𝑟,
(︁
𝐶𝑠𝑎𝑡 − 𝑟𝑄𝜑
)︁
can be less than zero; this
is clearly non-physical. This error could be mitigated using better model of oxygen
consumption kinetics, such as the first-order Michaelis-Menten model (Inman devel-
ops this model for the scaffolds used [3]). However, as a hardware design tool to
develop a platform that can oxygenate equivalently to the LiverChip performance,
this simplified model is sufficient.
Equation 3.4 allows us to see the bulk concentration (and in this model, the
concentration entering the oxygenator) in terms of oxygenator flowrate 𝑄𝑚 and oxy-
genation potential 𝜑. We can then estimate 𝜑 for a given geometry by using equation
2.21.
The steady-state bulk concentration is 𝐶 = 𝐶𝑠𝑎𝑡 − 𝑟𝑄𝑚𝜑𝑚 . Plotting (Figure 3-
9) this concentration against flowrate for different geometries (represented by ℎ
𝐴
),
we find a range of acceptable flow rate (𝑄𝑚) and geometry ( ℎ𝐴) combinations that
will provide adequate mass transfer (𝑟) without requiring a bulk concentration 𝐶
below a minimum acceptable lower limit (no less than zero). The solid lines are
the mixed model predictions for varying geometries, and indicate that a ratio ℎ
𝐴
of
below .001 would be required at a minimum of 5 𝜇L/s oxygenator flow rate to meet
the requirement of 150 𝜇M oxygen concentration flowing to the cells. The dashed
lines are model predictions using the measured oxygenation potential values shown
in Figure 2-21. The mixed model predicts that while the revision 1 prototype at 4
𝜇L/s will meet the functional requirement of 150 𝜇M steady state concentration, the
revision 2 prototype will not. However, this may only be the case for the first eight
hours of downward flow. An experiment discussed in Section 3.7 suggests that during
upward flow, the system behaves more like an inline system for oxygenator flow rates
near 2 𝜇L/s.
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Figure 3-9: Predicted steady-state bulk concentration for the mixed model, where
cell consumption rate 𝑟 = 100 [pmol/s]. The saturated concentration is 195 𝜇M
(see Appendix A). Predicted values for the revision 1 and 2 prototypes represent
the measured values for the oxygenation potentials 𝜑 substituted into equation 3.5
(dashed lines). Note that because the consumption rate 𝑟 is assumed to be fixed, this
model can include non-physical negative concentrations.
3.6 Inline vs. Mixed Equivalence
Comparing equations 3.2 and 3.5 shows the parameters required of the two sys-
tems to achieve equivalent oxygen concentration in the cell environment. In the inline
system, the cells experience the high concentration media directly from the oxygena-
tor. In the mixed system, the cells experience a mixed concentration because the
freshly oxygenated media is diluted by the bulk concentration in the MPS. Equating
the concentration going to the cells in these two scenarios,
𝐶𝑐𝑒𝑙𝑙𝑠,𝑖 = 𝐶ℎ𝑖𝑔ℎ,𝑖 = 𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑖𝜑𝑖
(1− 𝜑𝑖) (3.6)
𝐶𝑐𝑒𝑙𝑙𝑠,𝑚 = 𝐶𝑚 = 𝐶𝑠𝑎𝑡 − 𝑟
𝑄𝑚𝜑𝑚
(3.7)
𝑄𝑚𝜑𝑚 =
𝑄𝑖𝜑𝑖
(1− 𝜑𝑖) . (3.8)
Equation 3.8 gives a simple criterion for the desired 𝑄𝑚 and 𝜑𝑚 of a mixed system
required to match the steady-state concentration of a given inline system. Based on
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the oxygenation potential of 0.8 measured on the LiverChip at a flow rate of 1 𝜇L/s
(the scaffold perfusion flow rate recommended by CN Bio), equation 3.8 predicts that
𝑄𝑚𝜑𝑚 = 4 𝜇L/s is required to match the steady-state concentration observed on the
LiverChip (shown as a dashed line in Figure 3-10). Predicted and measured 𝑄𝑚𝜑𝑚
values are shown in Figure 3-10. This figure suggests that ℎ
𝐴
four times smaller than
that of the revision 2 prototype would be required to reach LiverChip equivalency.
This can also be seen by comparing the predicted concentrations in Figure 3-9 to the
steady state concentration of 170 𝜇M at 1 𝜇L/s shown in Figure C-2.
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Figure 3-10: Based on the mixed reactor model approximation (Section 3.5), the Rev2
oxygenator will not achieve the same steady state concentration going to the cells as
the LiverChip. To do so, the mixed reactor model predicts a flow rate of 4 𝜇L/s and
ℎ
𝐴
< .0005 would come close to equivalency.
This reduced ℎ
𝐴
could likely be achieved by making the oxygenator four times
longer, 2 times taller, or some combination of longer and taller (see Section 2.5).
3.7 Selective Sourcing Validation Experiment
The selective sourcing concept aims to pull media for feeding the cells from under
the oxygenator (potentially a high concentration zone), while feeding the oxygenator
from the opposite side of the MPS well (potentially low concentration). At very high
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oxygenator flow rates, we expect the MPS to be fully mixed, but it is difficult to
predict at what flow rate that mixing begins to dominate.
To assess the selective sourcing effect, the revision 1 prototype was used. Feeding
deoxygenated Bovine Serum Albumin (BSA) solution into the MPS and removing
partially oxygenated fluid created a net oxygen mass transfer out of the system,
simulating oxygen consumption by the cells (Figure 3-11).
MPS In
1 µL/s
1 µL/s
2-4 µL/s
MPS Out
Eﬄuent Collection
Oxygenator In
Oxygenator 
Out
Figure 3-11: To simulate oxygen consumption, fluid is pumped out of the MPS (MPS
out) and replenished with deoxygenated media (MPS In). In parallel, fluid is pumped
from the MPS into the spiral oxygenator, where it flows into the MPS after the oxygen
concentration is measured.
The experimental setup is shown in Figure 3-12. A 1% BSA solution in saline
(PBS) was deoxygenated by bubbling nitrogen in a glass jar which was vented outside
the incubator. A piece of 1/16 in. OD PEEK tubing withdrew fluid from the bottom
of the jar, below the bubbling tube to prevent bubbles from being pumped into
the oxygenator. A pneumatic diaphragm pump block pumped this deoxygenated
fluid into the bottom of the MPS, and withdrew partially oxygenated fluid from the
recirculation intake directly under the oxygenator output. Separately, two channels
on a second pump block were combined in parallel to flow fluid at 2 to 4 𝜇L/s into
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the oxygenator, drawing from the side of the MPS opposite the recirculation intake.
Fiber-optic oxygen probes (Lucid Scientific, Atlanta, GA) measured dissolved oxygen
concentration at the three locations marked by black arrows in Figure 3-11 and also
in the deoxygenation jar.
Deoxygenated
1% BSA 
solution 
Eﬄuent 
collection 
MPS Pump 
Block 
Oxygenator 
Pump Block Oxygen Probes 
Figure 3-12: The setup used to test the Rev1 prototype. The MPS pump block
both pumps deoxygenated BSA solution into the MPS, and also withdraws mixed
concentration BSA into the effluent collection at the same flow rate. Only three
oxygen probes are visible; "MPS In" is measured with a hidden probe in the bubbler
shown at left. Previous experiments showed that at 1 𝜇L/s, oxygen permeation
through the short length of PEEK tubing is negligible. The oxygenator pump block
circulates fluid through the oxygenator using two channels in parallel.
The concentration values measured at these locations are shown in Figure 3-13.
The recirculation was flowing upward at 1 𝜇L/s, as it does after the flow reversal at
eight hours. Before timepoint A, the oxygenator pump block was flowing at 2 𝜇L/s.
Shortly after timepoint A, it began pumping at 4 𝜇L/s. After some initial effects
(likely from clearing dead volume), the probes show an exponential rise to a new
steady-state value. The cause of an apparent steady increase at the oxygenator inlet
around timepoint B is unknown, but the observed effect is small.
If the system behaves more like an inline system, then the "MPS Out" reading
(point 2 in Figure 3-6), which the cells would be exposed to during upward flow,
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Figure 3-13: Oxygen probe data from the setup shown in Figure 3-12. Shortly after
time point A, the oxygenator flow rate was changed from 2 to 4 𝜇L/s. In the incubator
environment, oxygen saturation is at 195 𝜇M (see Appendix A).
should be the same as the oxygenator output, "Oxy. Out" (point 3 in Figue 3-6).
If, on the other hand, the system behaves like a lumped fully mixed system, "MPS
Out" should match the predicted steady state concentration value given by equation
3.5. Figure 3-14 shows this comparison at two different flow rates. At timepoint A (2
𝜇L/s), the simulated consumption rate 𝑟′ = 1 [𝜇L/s]×(𝐶MPS out−𝐶MPS in) [𝜇M] = 178
pmol/s and 𝜑 = 0.86. At timepoint B (4 𝜇L/s), 𝑟′ = 165 pmol/s and 𝜑 = 0.73. It
appears that in both cases, the system behaves closer to an inline system at 2 and 4
𝜇L/s, though less so at 4 𝜇L/s. This suggests that the model developed in Section 3.5
is a very conservative lower bound that is more applicable at higher flow rates than
at lower ones. Further, while the mixed model assumed in Figure 3-10 suggests that
higher flowrates yield better performance, these data suggest the opposite occurs at
lower flow rates, and an inline model is more appropriate. Because the inline system
is more effective, keeping the system in this unmixed regime can yield higher oxygen
concentration delivered to the cells. Note that the simulated oxygen consumption
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rate 𝑟′ is a function of the "MPS Out" concentration, and therefore different between
timepoints.
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Figure 3-14: Concentration readings at time points A and B in Figure 3-13. Oxy.
Out is the oxygenator output, which would go to the cells in an inline configuration.
MPS Out is what goes to the cells in the selective sourcing configuration described.
Concentration going to the cells in the mixed model is predicted from equation 3.5,
where 𝜑 is calculated from the probe readings at the specified time point, and the
simulated consumption rate 𝑟′ is calculated from measured concentrations as 𝑟′ =
𝑄MPS(𝐶MPS out−𝐶MPS in) in [pmol/s], where 𝑄MPS is 1 [𝜇L/s] and the concentrations
are in [𝜇M]. The mixed model underestimates the oxygen concentration relative to
the experimental results.
This simulated oxygen consumption experiment is challenging to perform with
the revision 2 platforms because the pumping is on-board and difficult to interrupt.
However, because the MPS well geometry is the same between revisions 1 and 2, we
expect that the trend shown in Figure 3-14 will hold for revision 2 as well, and at an
oxygenator flow rate of 1-2 𝜇L/s, the inline model will give a better prediction of the
steady state oxygen concentration of media going to the cells. While using the mixed
model would lead to selecting an oxygenator flow rate of 3 𝜇L/s or above, Figure 3-15
suggests that if the selective sourcing behaves like an inline system at low flow rates,
a flow rate of 1-2 𝜇L/s would in fact give a higher cell feed concentration.
This selective sourcing effect is only expected to occur after during upward flow,
when the cell feed pulls from under the oxygenator output. In the first eight hours
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Figure 3-15: The oxygen concentration of media going to the cells for a fixed cell
oxygen consumption rate 𝑟 = 100 pmol/s, predicted from measured revision 2 oxy-
genation potential data using the inline and mixed models (eqns. 3.6 and 3.7, respec-
tively).
flowing down through the scaffold, the oxygenator output and deoxygenated media
from the cells will flow into the MPS above the scaffold in the same location (as
shown at left in Figure 3-6). The system is therefore likely to behave more like the
mixed system, and should be operated at a higher oxygenator flow rate. Figure 3-15
suggests 3 𝜇L/s would offer the highest cell feed concentration at 125 𝜇M for the
mixed model; this is below the 150 𝜇M requirement, but may be acceptable for a
short duration.
3.8 Summary
The selective sourcing concept was chosen as a compromise to balance the fab-
rication considerations that favored the mixed co-flow concept against the higher
concentration achieved in an in-line system for a given consumption rate and oxy-
genator efficiency. The mathematical models developed to describe the in-line and
mixed systems serve to bound the expected steady state concentration going to the
cells. Empirical testing with the revision 1 prototype simulating oxygen consumption
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indicate that for upward flow, the system behaves like an inline system at low oxy-
genator flow rates. This indicates that the revision 2 system will achieve 150 𝜇M cell
feed concentration (requirement 2) after eight hours, while not meeting the require-
ment during the initial downward flow. Whether this is the case in practice, and the
impact that it might have on the cells, are questions needing further investigation.
Reversible recirculation (requirement 1) is allowed by decoupling the oxygenator
and recirculation loops, and the degrees of freedom are coupled across replicates as
described in Section 1.4.1 (requirement 3).
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Chapter 4
Scaffold Attachment
This chapter explores several methods for securing the cell culture scaffold and
preventing media from bypassing the cells. This design effort was secondary to the
oxygenator and flow circuit designs, and the prototyping occurred primarily in the
time that the revision 2 platforms were out for fabrication. Due to this constrained
time-line, a low-risk elastomeric sealing method was used for the revision 2 platforms
despite the potential drug and biomarker adsorption limitations of elastomers. In
addition to documenting the attachment method used, this chapter aims to provide
ideas to speed the development of a non-elastomeric solution in future efforts.
Section 4.1 describes the method used in the LiverChip and its limitations. Section
4.2 establishes the requirements for a new design. Sections 4.3 and 4.4 describe the
concepts explored and which concepts were chosen to prototype. The design and
prototyping process is described in Section 4.5.
4.1 Current Approach and Limitations
On both the LiverChip platform and the platform developed for this thesis, the
cells are grown on a perforated polystyrene scaffold (CN Bio Innovations, Welwyn
Garden City, UK). On the LiverChip, as shown on the left in figure 4-1, a polypropy-
lene retaining ring secures the scaffold by means of an interference fit with the wall
of the culture well. A user installs the ring by pressing down on it with a 10 mm
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outer diameter tube. Under the scaffold is a filter and a scaffold support. The filter
serves to diffuse the flow and, in combination with a membrane capacitor, reduce the
pulsatility of the diaphragm pumps [1, 19]. During the initial downward flow that
seeds the cells on the scaffold, the scaffold support prevents the filter from separating
from the scaffold. Separation of scaffold and filter would allow cells to leak between
the two and not bind to the scaffold openings.
The LiverChip retaining ring does not apply a consistent downward force, and
thus relies on the deformation of the thin filter during installation, and its subsequent
elastic response, to provide sealing, as illustrated in Figure 4-2. Because the filter is
so thin, any force generated is negligible, and the leak path around the scaffold is not
sealed in a strict sense. In a looser sense of sealing, the majority of the media does in
fact flow through the scaffold rather than taking the higher-resistance path through
the filter edge-wise and around the scaffold, because the flow resistance through the
LiverChip scaffold is comparatively low. However, when using higher resistance scaf-
folds, leaking around the scaffolds has been observed. This can result in uncertainty
about local shear stresses and the transport rate of oxygen and nutrients to the cells,
confounding interpretation of experimental data.
A design pre-dating the LiverChip, described by Domansky et al. [2], used a
silicone o-ring to provide the elastic deformation and conformal contact required to
maintain a seal. Silicone, however, can absorb lipophillic drugs and biomarkers,
confounding an experiment that measures such compounds. Viton, a fluoroelastomer
used for the revision 2 platform, does not appreciably absorb these compounds, and its
adsorption of many relevant biological compounds is negligible (absorption describes
incorporation of compounds into the bulk of material, while adsorption refers to
binding only at the surface). Even so, other compounds such as some steroids [29]
can be adsorbed in significant amounts, so a non-elastomeric solution is preferable
long-term to avoid unwanted adsorption.
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Viton Gasket
Scaold
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Scaold support
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LiverChip 6xRL Rev2
Figure 4-1: The scaffold assembly for the LiverChip (left) and reduced volume Rev2
platform (right). Both platforms use the same polystyrene scaffold (CN Bio Innova-
tions, Welwyn Garden City, UK) and filter (Durapore 5 𝜇m SVPP membrane filter,
MilliporeSigma). Cells are initially seeded above the scaffold while the fluid is flowing
downward and collect in the scaffold pores where the filter prevents them from pass-
ing through. The scaffold support prevents the filter from deflecting, which would
allow the cells to move in between the filter and scaffold. After eight hours, the cells
have attached to the scaffold walls and the flow is reversed to prevent cell growth
from clogging the pores. The retaining ring holds the assembly in place and aims to
prevent fluid from flowing around the scaffold and bypassing the cells. The Rev2 as-
sembly improves this sealing function with a Viton gasket. The membrane capacitor,
in combination with the filter and scaffold resistance, reduces the pulsatility of the
flow, reducing the peak pressure below the scaffold (the membrane is not shown for
the LiverChip on the left).
4.2 Scaffold Attachment Requirements
The following requirements were used to guide the design of the scaffold attach-
ment feature.
1. Attachment method must withstand at least 5 N of upward force
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Figure 4-2: During installation of the LiverChip scaffold, the user presses down on the
retaining ring, compressing the filter against the scaffold support. After installation,
the thin filter provides minimal reaction force, and the system functions primarily by
relying on the flow resistance of the filter and scaffold in the vertical direction being
much lower than the resistance through the edge-wise filter.
To maintain the scaffold in position and prevent fluid from bypassing
it, the device that applies downward pressure on the scaffold must not
become dislodged. The maximum fluid pressure multiplied by the area
of the scaffold gives an upper bound on the upward force exerted on the
scaffold assembly. The driving air pressure of the pneumatic pumps is
typically 40-60 kPa, so the maximum fluid pressure can be no greater
than 60 kPa. The scaffold diameter is 10 mm, so the required force is
4.7 N. This is a highly conservative upper bound on force; the membrane
capacitor under the scaffold, combined with the fluid resistance across
the scaffold assembly, will limit the peak pressure at the scaffold to below
the pump driving pressure. For the existing scaffold, the very low flow
resistance means that the upward force is minimal. However, alternative
scaffold designs are under development at MIT in the Griffith Lab that
may have a greater flow resistance, and a design that accommodates this
higher pressure drop would be useful in this and other applications.
2. Scaffold should leak no more than 0.1 𝜇L/s at a pressure differential
of 40 kPa
88
It is important to know the flow rate of fluid past the cells to calculate
shear stresses and oxygen consumption; leaking around the side of the
scaffold, rather than passing through it, will introduce error in these
measurements. Ideally, the scaffold would be fully sealed and no leaking
would occur. However, a leak rate of 0.1 𝜇L/s is only 10% of the overall
flowrate (1 𝜇L/s), and the high pressure peaks would be both short in
duration and likely lower than 40 kPa, due to the membrane capacitor.
This limited leaking was agreed upon by the biology team as acceptable,
understanding that full sealing is desirable.
3. Insertion force should be less than 50N
The mean maximum strength of subjects ages 21-60 pushing down with
fingers on an object at seat height has been measured to be above 100
N for female subjects and 200N for male subjects [30]. 50% of the lower
value provides a reasonable upper limit for insertion.
4. Attachment method must not damage scaffold or other components
Insertion and removal should damage neither the scaffold nor the plat-
form itself. Because the platform is reusable, it must withstand many
insertion/removal cycles, but a specific lifetime requirement was not de-
termined within the scope of this project.
5. Attachment method must not occlude holes on cell scaffold
For flow to pass evenly through each hole in the scaffold, the attachment
device must not cover the holes. This confines the sealing footprint area
available on the scaffold to a band from 8 mm inner to 10 mm outer
diameter.
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6. Material must be cell- and drug-compatible
This requirement is explained in the general system requirements de-
scribed in Chapter 1, but is included here for further clarification. Incor-
porating a fluoroelastomer such as Viton will allow more reliable sealing,
but the biology team was uncertain about its tendency to bind certain
drugs. While non-elastomeric materials such as polysulfone, polystyrene,
or polypropylene are preferred, the team agreed that for the pilot exper-
iments planned, Viton would be an acceptable material.
7. Design should allow a path to mass-manufacture, or be reusable
If the retaining ring is disposable, there must be a feasible method of
mass-manufacture, such as injection molding. Alternatively, reusable
devices could allow slower and more expensive processes. While the
devices made within the scope of this project need not be mass-manu-
facturable, the design should be chosen and pursued with this end in
mind.
4.3 Scaffold Attachment Concepts
This section presents concepts developed for sealing. The aim of these designs was
a more deterministic method of applying a downward force to prevent flow around
the scaffold that met the requirements described above.
4.3.1 Sealing Lands
If the contact area between the filter and scaffold support is reduced to a narrow
band, a given downward force will produce a higher sealing pressure (Figure 4-3).
This can be used with any of the other concepts, although it is unnecessary if an
elastomer is used for sealing.
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Retaining Ring
Scaﬀold and Filter
Figure 4-3: Sealing land: Reducing the contact area on the scaffold support to a
narrow band increases sealing pressure for a given downward force.
4.3.2 Bi-Stable Spring
A bi-stable belleville washer, shown in Figure 4-4, could provide a strong down-
ward force by engaging with features on the MPS wall. If a conical washer is suffi-
ciently thin and elastic, it can be stable in the two positions shown, and will resist
being flattened. Using a stainless steel washer, this may deliver the required forces
in a compact mechanism. The primary challenges are ensuring that the outer edge
reliably catches the MPS wall, and providing a means of easy removal. The latter
might be accomplished by providing a hole or a tab punched through the middle
portion of the ring, which a custom tool could use to flip the spring to the original
upward position. Once in this position, it could be easily removed with tweezers.
4.3.3 Angled Ring and Lip
One simple improvement over the LiverChip retaining ring is to use an angled face
to direct some of the radial force exerted by the ring downward to provide sealing
force on the scaffold (Figure 4-5). The angled face can be on the retaining ring, or on
the MPS wall. The main challenges with this concept are 1) achieving adequate radial
expansion while staying within the elastic limit of the material, and 2) providing a
convenient removal method.
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Figure 4-4: Bi-stable spring: A) A bistable spring, such as a belleville washer, can
engage with features on the MPS wall to provide a downward force on the scaffold.
B) In its relaxed state, the outer diameter of the washer can fit within the MPS wall.
A downward force initiates deflection. C) As the washer deflects past the equilibrium
point, the outer edge expands, and a ramp on the MPS wall pushes this edge upward.
This creates a small gap under the washer required to push it past equilibrium. D)
The pocket in the MPS wall is short enough that it catches the edge of the washer
before the washer can relax to the full height. E) The washer may require tabs or
some feature for removal.
4.3.4 External Screw Mount with Spring
The above concepts attempt to solve the challenge of providing adequate sealing
force in a small, fully submerged mechanism. The concept presented here is to attach
to the platform outside of or further up the MPS well, outside of the fluid, as shown
in Figure 4-6. This provides more options for attachment, such as a screw or bayonet
mount. This fixes the position of the retaining device, and a predictable downward
force is provided by an elastic element, whether a solid tube with a low Young’s Mod-
ulus, a spiral or wave spring, or a custom flexure. The main development challenge
with this concept is ensuring that fluid does not wick up between the spring and the
MPS wall, depleting the fluid at the bottom of the MPS and increasing the total
volume required to keep the cells covered. This might be mitigated by keeping the
gap small enough that the fluid volume is acceptable, or by use of a hydrophobic
92
A) B) C) D)
E)
Figure 4-5: Ring and lip: A) An elastic chamfered ring with an outer diameter slightly
larger than the MPS wall diameter relaxes into a groove in the MPS wall. B) A
downward force on the ring compresses the filter material and allows the ring to relax
further into the groove. C) when the downward force is released, the radial outward
force of the ring results in a force downward on the filter and scaffold assembly due
to the chamfered edge. D) Various existing expanding ring designs could increase the
allowable deflection over a solid ring. E) One such design involves a zig-zag pattern
cut into a ring to convert hoop compression into bending of many small beams in
series, thus allowing greater deflection while remaining within the material elastic
limit.
material or coating.
Figure 4-6: External screw mount: A screw or bayonet mount to the top of the MPS
compresses an elastic tube (left) or a spring (right) to provide a downward sealing
force on the scaffold assembly.
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4.3.5 Snap Fit with Flexure
Similar to the external screw mount, the concept shown in Figure 4-7 uses a point
of attachment outside of the fluid. A simple snap fit can engage with a pocket in the
MPS wall and provide a downward force by elastic energy stored in the snap feature
itself, or in a separated dedicated spring element. This concept, like the external
screw mount concept, faces the challenge of wicking fluid away from the bottom of
the MPS, with similar mitigation strategies.
Figure 4-7: Snap fit: A cantilever snap feature engages with a pocket in the MPS
wall. The downward sealing force can come from deflection of a beam at on the snap
feature (left), or from a separate spring element, such as a flexure cut from a single
tube (right).
4.3.6 Deflecting Beam
As a means of storing elastic energy and providing a downward sealing force, a
deflecting beam could be integrated with an interference-fit ring (Figure 4-8). If the
beam deflection remains elastic, this can provide a repeatable sealing force. The
compact size and simplicity of the design may be outweighed by the challenge of
achieving high enough forces without exceeding the elastic limit of such a small beam,
as well as manufacturing and integrating a convenient means of removal.
Another variation of this concept was explored during development, where a beam
element compresses both radially and axially. An example of is shown in Figure 4-9
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Figure 4-8: Deflecting Beam: Examples of ring cross-sections that use a deflecting
beam to provide a downward sealing force. A) An outer ring interferes with the
MPS wall, and this radial force results in a frictional force that keeps the ring in
place. When the user presses the ring downward, a thin section of the ring deflects
elastically in bending, providing a consistent downward sealing force that is less than
the friction force against the wall. B) By incorporating a height difference between
the beam and the base of the ring, a repeatable deflection (and therefore force) can
be achieved, regardless of the insertion force F. C) A rotated configuration reduces
the footprint of the ring, potentially providing a greater force without occluding the
scaffold.
The advantage of such a method is that the radial stiffness can be lower than that
of a ring, meaning that the holding force is less sensitive to small variations in well
diameter. However, to achieve the high forces specified in the requirements at such a
small size, the elastic stress limit of the ring must be significantly higher than polymers
allow. Stainless steel may perform adequately, but gouging the polysulfone MPS walls
becomes a significant risk, and the spring must have a large contact radius to avoid
excessive contact stresses in the polysulfone. While exploration of this concept was
cut short by schedule constraints, the challenge appeared to be in finding a beam
geometry that was appropriately stiff in both directions at reasonable deflections, but
that did not exceed the material yield stress. Making a beam wider will increase its
stifness linearly without increasing the maximum material stress, but this makes the
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beam stiffer in the perpendicular direction as the width to the third power. If the
stiffness requirements in each direction are similar, this results in a roughly square
cross section and the limiting factor becomes material yield stress. A material such
as a superelastic nickel titanium alloy could resolve this, potentially being cut from
a tube as many stents are, but the cost seems to quickly outweigh any benefit of
a purely friction-based approach. This approach is worth considering, however in a
configuration where the beams catch on pocket features in the MPS well, and the
holding force is not from friction alone.
Figure 4-9: An alternate deflecting beam concept: the beams act as both the radial
spring element that generates friction force, and also the vertical spring that is loaded
during installation to provide a downward sealing force.
4.3.7 Tilting Ring
With an interfering ring of a triangular cross-section, as shown in Figure 4-10,
if the outer top edge is pressed below the inner top edge, the hoop compression of
the inner bottom edge results in reaction forces which create a moment on the ring.
When installed, this moment is balanced by the frictional force from the wall and the
compressive sealing force on the scaffold assembly.
The primary challenge to developing this concept is manufacturing to tight toler-
ances. While the existing ring can plastically deform without much consequence, the
tilting ring concept would require elastic deformation to produce a reliable sealing
force. The high stiffness of rings in radial compression results in a narrow window of
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radial deflections that provide adequate friction force but avoid plastic deformation.
One embodiment of the tilting ring concept uses deflection of multiple projections
to provide the required twisting of the ring, rather than pushing on the outer edge
(Figure 4-11). These projections could then be used for removal. The projections
must be stiff enough to twist the ring outward against its own elastic force as well as
the friction force on the wall. In practice, it is challenging to make these beams stiff
enough to cause adequate torsion at this small scale.
A) B)
Figure 4-10: Tilting Ring: A) A downward force on the outside top edge results in a
stored moment from the compression of the inside bottom edge. Because the outside
top edge is constrained by friction against the MPS wall, this results in a downward
sealing force on the scaffold. B) The deformation, and therefore reaction force, can
be made more repeatable by a feature that limits the deflection distance ℎ.
A) B) C)
Figure 4-11: Tilting ring with deflecting clips: A) An insertion tool displaces multiple
protruding clips radially outward and down, causing the outer edge of the ring to
slide downward on the MPS wall. B) When the tool is removed, the ring partially
untwists, exerting a downward force on the scaffold. C) To remove, a tool with fine
teeth engages with the protrusions to remove them.
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4.3.8 Wave Spring
The wave spring, shown in figure 4-12, is a variation on the tilting ring concept,
using a waved piece of stainless steel wire bent into a shallow cone shape. The smaller
diameter is placed down, and the larger diameter, which is slightly larger than the
well, is pushed down. The crests at the top are held by friction against the well wall,
and as they are pushed downward the bottom crests of the spring make contact with
the scaffold, twisting the ring inward and causing reaction forces that push down on
the scaffold to seal. The wire must be stiff enough to resist this twisting. The primary
advantage that this method has over the retaining ring is that the waves introduce
more compliance to the ring, allowing looser tolerances in the diameters of the ring
and the well.
A) B)
Figure 4-12: Wave spring: A) The ring consists of a ring of stainless steel wire that
has waves that have been formed into a shallow cone. B) Similar to the tilting ring,
when the top crests are pushed down by the installation tool, this induces reaction
forces that provide a downward sealing force against the scaffold.
4.3.9 Ring with Elastomer
If an elastomer such as Viton can be used for the particular experiment per-
formed, their high yield strains and low Young’s moduli offer reliable sealing at a
small size. Possible configurations are shown in Figure 4-13. The low yield strain of
non-elastomeric materials such as polystyrene or stainless steel requires long beam
lengths to reach high forces while remaining elastic, and when directly compressed,
their high Young’s moduli result in high forces at deflections below machining tol-
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erances. Elastomers, by contrast, can deform under low forces to make conformal
contact with mating surfaces, which improves sealing, and can store elastic compres-
sive forces at reasonable deflections without plastically deforming. An elastomeric
seal is therefore desirable when there is no risk of adsorbing lipophillic compounds.
Due to these sealing advantages, it is worth further assessment of the sorption poten-
tial of the small surface area exposed to circulating media, or of materials other than
Viton that might be acceptable.
A) B) C) D)
Scaold
Filter
Figure 4-13: Elastomeric sealing: A) A constrained volume causes a downward force
to provide sealing against both the MPS wall and the scaffold. B) This same effect
could be achieved by a round gasket pressed into a gap between the MPS wall and
the scaffold. C) If a ring with a smooth interference fit against the wall is used, the
radial force may provide adequate sealing against the wall, and only a seal against the
scaffold is necessary. D) If the gasket is under the filter, as described by Domansky
[2], there is a potential leak path through the filter. The scaffold support is not shown.
4.4 Scaffold Attachment Concept Selection
Many of the concepts described above appear promising, but were excluded due
to scheduling constraints. To provide adequate time for manufacturing, the revision
2 platform was released before much of the design effort on the scaffold attachment
occurred. The Rev2 platform was designed to accommodate the existing retaining
ring with a removable scaffold support to mitigate risk, with the goal of developing
improved sealing method while the platform was out for production.
The design was therefore limited to friction-based approaches, such as the de-
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flecting beam, the tilting ring, and a ring with a Viton gasket. The tilting ring was
pursued as the easier to manufacture non-elastomeric strategy, while the ring and gas-
ket approach was developed in parallel to ensure having a functional sealing option
on schedule.
4.5 Scaffold Attachment Design and Prototyping
4.5.1 Testing Apparatus
The test fixture shown in Figure 4-14 was built to test the sealing of retaining
ring prototypes. The machined pockets simulate the MPS well. The pockets were
filled with water until an air-water interface was visible in the connected tube, and the
retaining ring prototypes were assembled with the usual filter and a solid polyester disc
replacing the scaffold to simulate full occlusion. The tube was then lightly pressurized,
starting at <1 kPa, and slowly increased to 40 kPa (measured with Fluke 717 300G
Pressure Calibrator). The air-water interface in the tube was observed to move in
two cases: 1) while pressure increased, due to deflection of the polyester disk, and
2) when fluid was leaking. To avoid confounding these two effects, the pressure was
therefore maintained static for 60 seconds at discrete pressure intervals to observe
movement of the interface due to leaking alone. The inner diameter of the tube is
approximately 1/16 in., allowing an estimate of leak rate by measuring the time over
which the interface moved a known distance. Interface movements of less than 1 mm
were observable, allowing detection of leaking lower than 0.2 𝜇L/s. A hold time longer
than 60 sec can be used to detect slower leaks. With this setup, the existing retaining
ring was observed to leak in excess of 1 𝜇L/s at pressures below 1 kPa, which was
the lower detection limit. Because of possible differences in diameters, it is difficult
to predict from this test the ring’s performance in the actual LiverChip platform, but
the presence of removal pockets cut into the wall of the well where the LiverChip
retaining ring seals will likely limit any improvement that could be obtained from a
smaller diameter well.
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Retaining Ring
Polystyrene
Disc
Pressurized Tube
10 mm Dia. Pocket
Figure 4-14: A fixture for leak testing retaining ring prototypes. Two pockets 10 mm
in diameter, one with the sealing land (left) and one without (right), were CNC ma-
chined into polysulfone. Sections of these profiles are shown. A pneumatic connector
(LEGRIS 3171-53-20, Parker Hannefin, FR) sealed to the polysulfone with an o-ring
(hidden) and connected to 1/8 in. outer diameter (1/16 in. ID) tubing. Retaining
rings were tested with a 9.8 mm diameter polyester shim the same thickness as the
scaffold (0.10 in.) to simulate a fully occluded scaffold.
The diameter of the pocket is critical to the retaining ring performance, as it deter-
mines, for a given ring geometry and friction coefficient, the holding force achievable.
To measure the internal diameter, a metrology grade rubber was cast into each pocket
(see Figure 4-15), and measured with a micrometer (293-340, Mitutoyo, JP). To avoid
compressing the rubber, the diameter was taken when it could no longer slide easily
through the micrometer jaws. The pockets with and without the sealing land mea-
sured 10.02± 0.01 mm and 9.98± 0.01 mm, respectively. For machining the pockets,
the toolpaths were identical before the final cut to form the sealing land. This final
cut put the outer cutting edge of a smaller end mill at the same outer diameter,
making a second cutting pass on the same surface, which may be responsible for the
small difference in diameters.
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Figure 4-15: Casts for measuring pocket diameter. The casts are made from a low-
shrinkage metrology grade rubber (Reprorubber Thin Pour, Flexbar, Long Island,
NY).
4.5.2 Tilting Ring
The tilting ring concept described in Section 4.3.7 is installed by pushing the outer
edge of the top surface downward, where it stays due to friction with the MPS wall.
The elastic compression of the inside edge acts as a spring, applying a downward
sealing force on the scaffold assembly. Several prototypes were machined to test the
efficacy of this approach; the three main profiles explored for the tilting ring concept
are shown in Figure 4-16. For profiles B and C, the removal clips were omitted for
testing purposes.
The tilting ring prototypes were fabricated from high impact polystyrene on a
desktop CNC mill (Othermill Pro, Bantam Tools, Berkeley, CA). CAD and toolpaths
were generated in Autodesk Fusion 360. The primary fabrication challenge was index-
ing the part between milling operations on opposite faces. The most effective method
used for these prototypes, illustrated in Figure 4-17, was to mill the bottom features
on a cylindrical blank from the flat stock (Figure 4-18-A), then to press-fit this blank
onto a machined post before machining the removal clips on the top. Because the
locating post remained fixed after milling, its center was known, and the top features
could be machined concentric to the bottom features.
While the LiverChip retaining ring is inserted using a tubular punch with a flat
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A) B) C)
D)
Removal Clip
Figure 4-16: Cross-sections of the three main tilting-ring prototype. The MPS wall is
to the left of the profile, and the ring center is to the right. A) The first profile sealed
up to 25 kPa. B) This triangular profile sealed up to only 5 kPa. C) A T-shaped
profile sealed up to 25 kPa. D) Removal clips were included on prototype A, but not
on B or C. All prototypes were nominally 10.06 mm outer diameter and 1 mm tall.
A) B) C)
Figure 4-17: The fabrication process used for retaining ring prototypes with removal
clips. A) First, the bottom features were machined into a cylindrical blank (endmill
shown in blue). B) A locating post (red) was machined into sacrificial material, and
the cylindrical blank was press-fit onto the post. C) With the center of the post
known, the removal clips and other top features of the ring could be machined.
bottom, the tilting ring concept requires an insertion tool with a beveled edge to
apply force only at the outer edge (Figure 4-19). For the ring with removal clips, the
insertion tool requires clearance pockets, and therefore does not press down on the
outer edge in the two locations behind each clip.
On first installation of the tilting ring with profile A (Figure 4-16-A), fluid accu-
mulated behind each clip where the insertion tool had not pressed down the outer
edge. After pressing the clips radially outward by hand, the ring sealed up to 25 kPa
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Figure 4-18: Scaffold Retaining Rings: A) The first machining operation resulted in
the blank shown, which was then inverted on the locating post before the removal
clips were machined from the other direction. B) Two clips allow removal; their
section is shown in Figure 4-16-D. The presence of these clips required an insertion
tool with clearance notches, shown in Figure 4-19-B. C) A prototype with six clips was
fabricated to evaluate the tilting ring variant shown in Figure 4-11. D) The existing
LiverChip retaining ring consists of a polypropylene annulus with a rectangular cross
section.
in the test block pocket that included a sealing land, using a standard filter and the
polyester scaffold simulator disc. A ring with profile B, without removal clips, leaked
at 5 kPa. This was thought to be caused by the increased bulk and therefore stiffness
of the profile. Profile C, which is less stiff to twisting, sealed up to 25 kPa.
These results are promising: while below the target 40 kPa, this is far better
performance than the existing retaining ring exhibits. However, the performance is
critically dependent on the extent of interference between the ring and the pocket.
The actual interference in these tests was below our ability to measure, partly because
the rubber cast and retaining rings both deflect when measured with physical means.
An optical comparator did not offer the precision needed. To emphasize the risk of
these tight tolerances: when the tool was changed from a 1/8 in. end mill to 1/16 in.,
and the tolerance of linear interpolation was adjusted slightly, rings of the same profile
no longer sealed beyond 1 kPa or so. Given our time constraints, this supported the
decision to use elastomeric gaskets for near-term experiments.
The six-clip prototype was built to evaluate whether the twisting of the ring could
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A) B) C)
D)
Clearance Pockets
Figure 4-19: A) The retaining ring insertion tool for the liverchip is a polysulfone
tube with a flat rectangular edge on the bottom. B) The tilting ring concept require a
beveled edge, and clearance slots to accommodate the removal clips. The material is
aluminum for prototyping only. C) A beveled insertion tool was fabricated for tilted
ring prototypes without removal clips. D) An insertion/removal tool was designed
and 3D printed to test the prototype with six removal clips, but the design applies as
a removal tool for the two-clip design as well.
be accomplished by deflecting the removal clips alone, rather than pushing on the
outer edge. This prototype did not seal, likely because the clips were too weak to
overcome both the ring stiffness and the wall friction to twist the ring enough that in
provided a downward force after the clips were relaxed. While further development
might yield a working prototype, it seems challenging to achieve the required clip
stiffness if the ring is to be a uniform material.
4.5.3 Beveled Ring with Viton Gasket
An elastomeric sealing solution was developed as a short-term solution for exper-
iments where Viton is an acceptable material but which require better sealing than
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the LiverChip retaining ring can provide. It offers several advantages over the tilting
ring described above. First, the tolerances are looser than for the tilting ring concept
because plastic deformation is allowable in this case. Second, an axially symmetric
design allows fabrication on a lathe, where tight diametric tolerances are easier to
maintain. Third, the increased deflection and conformal contact of the elastomer will
provide a more reliable seal. The gaskets and ring described below sealed to 40 kPa
in the test fixture described above.
The assembly, shown at right in Figure 4-1, consists of a chamfered retaining ring
and a rectangular cross-section Viton gasket. The chamfered retaining ring design
was chosen to direct force on the gasket both downward and radially outward, sealing
both possible leak paths around the gasket, while being easier to fabricate than the
stepped design shown in Figure 4-13-A. The ring is chamfered on the top and bottom
and can be inserted in either orientation, so the user does not risk inserting it upside-
down. The gasket was punched from a 1/64 in. thick Viton sheet using the custom
punch shown in Figure 4-20 and a 1-ton arbor press.
Figure 4-20: This two-part punch machined from 4140 Alloy steel was used to produce
the Viton gaskets. The shorter punch is used first, then the longer punch is inserted
inside the shorter one to form the internal diameter of the gasket.
The chamfered retaining ring was fabricated from polystyrene on a lathe with a
custom-ground cutoff tool, to an outer diameter of 10.10± .01 mm. This method
was aimed at quickly fabricating the 20 rings needed for pilot experiments; for larger
quantities, a Swiss screw machine shop could fabricate these rings to high precision
on a six to eight week time-line. The fabrication process is shown in Figure 4-21.
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D) E) F)
X
Z
G)
Figure 4-21: Fabrication of the chamfered retaining ring. A) First, a custom-ground
cutoff tool is advanced in the x direction to shape the two chamfers. B) The cutoff
tool is then retracted to a second position and moved in z while the left edge of
the cutoff tool cuts the required outer diameter. C) A final drilling operation both
machines the inner diameter and separates the ring from the stock. D) The ring
profile is checked with an optical comparator. The outside edge (at center of cross-
hairs) is 0.5 mm wide. E) The top and bottom of the ring are sanded flat using
an aluminum and Delrin fixture. F) A section of the sanding fixture shows how the
Delrin plunger pushes the retaining ring flat while the aluminum cylinder constrains
it. G) A diagram of the cutoff tool shows the v-groove that defines the chamfers, and
the left side edge of the tool that extends further than the right and defines the outer
diameter of the ring.
To remove the ring, a tool was fabricated from 316 stainless steel rod (Figure
4-22). While this is a simple and effective solution, it does require user care to avoid
damaging the platform itself.
The scaffold support (Figure 4-23) is similar to the LiverChip support, except that
it is a separate component from the platform itself. This served two purposes: first,
the scaffold sealing method was not determined when revision 2 parts needed to be
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Figure 4-22: A tool for removing retaining rings from platforms without tweezer
pockets. Top: The point can either pry under the retaining ring or dig into its
inside bore. In the former case, the user must be careful not to gouge the MPS wall.
The length of the point and curvature of the heel are such that the point is pushed
into the retaining ring, but the heel does not touch the scaffold. Bottom: A simple
stainless steel guard ensures that the point does not injure the user during storage
and handling, nor perforate the sterilization pouch.
released, and second, separating the scaffold support allowed the bottom of the MPS
to be much higher than it is in the LiverChip. Raising the MPS well is necessary to
ensure passive draining of excess volume—introduced by the media exchange pump—
from the MPS into the effluent collection. The LiverChip does not have automated
media exchange, and thus has no spillway, so the MPS height is not a concern on
that platform.
The scaffold support was machined from a 1 mm thick polystyrene tissue culture
lid (Costal universal lid #3099, Corning Incorporated, Corning, NY) using the Other-
mill Pro desktop mill. Each face was sanded with 1000 grit sandpaper, and additional
deburring was performed with a toothbrush under a stereo microscope. For larger
batches, a cryogenic deburring method such as dry ice blasting could be employed.
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Figure 4-23: The scaffold support for the Rev2 prototype. A) The design is similar
to the LiverChip scaffold support, but is removable from the platform. B) A cross-
section of an older version of the scaffold support, with the filter, scaffold, Viton
gasket, and chamfered retaining ring, from bottom to top. The scaffold, filter, and
scaffold support are slightly under 10 mm so that they drop into the well. C) The
support was machined from polystyrene on a desktop mill. Many burrs are visible.
D) Lapping both sides with 1000 grit sandpaper and scrubbing with a toothbrush
removed the burrs, which was confirmed with a stereo microscope.
4.6 Summary
This chapter describes many potential solutions to the problem of fluid bypassing
the cell scaffold. The retaining ring with a Viton gasket presented above was de-
veloped as a short-term solution to provide significantly better sealing (>40 kPa vs
<1kPa for the LiverChip retaining ring). The tilting-ring approach showed promise,
sealing to 25 kPa, but is fundamentally limited by the narrow machining tolerances
required to prevent plastic deformation. In future development, we suggest designing
the scaffold retaining device in tandem with the well geometry, rather than confining
oneself to a friction based approach in the existing well.
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Chapter 5
Platform Design, Manufacturing, and
Testing
5.1 Design
The Six replicate Reduced volume Liver culture platform (6xRL) integrates the
oxygenator, media circulation, and scaffold attachment designs discussed in Chapters
2, 3, and (4). This chapter discusses the integrated design (Section 5.1.1) and some
preliminary testing (Section 5.2); some of these test results will need to be repeated
with new pneumatic plates that have not arrived at the time of writing.
5.1.1 Overview
The primary contribution of this work is in the spiral oxygenator design; many
other components of the platform, such as the pumping, pneumatic manifold design,
and passive volume control (spillways) are technologies developed in the lab that
have been demonstrated on other platforms [2, 6]. While the technologies may be
proven, there are challenges and compromises involved in applying them to a new
configuration.
The components of the revision 2 platform are shown in Figure 5-1, and in the
photos of Figure 5-2. Each of six replicate lanes consists of a media exchange reser-
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E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Figure 5-1: The platform consists of a fluidic top plate (polysulfone) and a pneumatic
bottom plate (acrylic) separated by an elastomeric polyurethane membrane. Each of
six replicate lanes consists of an oxygenator spiral, an MPS well, and a supply and
effluent reservoir for the programmable media exchange. Three diaphragm pumps per
lane control media exchange, oxygenator flow rate, and the MPS flow rate (perfusion
rate through the scaffold), respectively. The pneumatic channels are coupled across
lanes, so the flow rates in each lane are nominally the same for a given one of the
three functions.
voir, an oxygenator spiral, a microphysiological system (MPS) culture well, and an
effluent collection reservoir (Figure 5-3). The top plate is CNC machined from poly-
sulfone, with open fluidic features on the top connected through vertical holes to
closed passages and pumps on the bottom face. A polyurethane membrane (50 𝜇m
Aromatic Polyether Polyurethane film, extruded by American Polyfilm, Branford,
CT) separates the top plate from the pneumatic bottom plate, where raised sealing
lands seal the membrane against the bottom face of the top plate. Figure 5-3 shows
a single lane of the top plate above the sealing land on the bottom plate, and Figure
5-4 shows how the sealing land seals around channels cut in the top plate to form the
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Figure 5-2: A photograph of the 6xRL revision 2 platform. The acrylic pneumatic
plate is shown at left, and the fluidic top plate is shown at right. The polyurethane
membrane is not shown.
diaphragm pumps and fluid channels. The diaphragm pumps are described in detail
by Inman [19]. The platforms are held together by 1/2 in. long 4-40 screws with
Belleville washers, which act as preload springs.
Spillway
MPS Inlet
MPS Outlet
Oxygenator Inlet Media Exchange
Inlet
Media ReservoirEuent Collection
Start of Spiral
Recirculation
Pump
Oxygenator 
Pump
Media Exchange
Pump
Figure 5-3: An overview of a single lane. The inlet and outlet holes (top) correspond
to the indicated sealing points on the pneumatic sealing land (bottom).
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Figure 5-4: A section of the diaphragm pump geometry. A central pump chamber
and two valves allow for bi-directional volume-determined flow. See Inman [19] for
detail on the pump operating principle.
5.1.2 Programmable Media Exchange
Fresh media is stored in a reservoir designed to hold a maximum of 1 mL. The top
of the reservoir has a sharp edge designed to constrain the meniscus and minimize
the chance of fluid bridging between the reservoir and the oxygenator or neighboring
reservoirs (Figure 5-5). The media exchange pump shown in Figure 5-3 feeds fresh
media into the oxygenator channel. The resulting excess media volume is discharged
from the MPS by passive spilling through the spillway and into the effluent collection
(Chapter 6 discusses potential actively pumped designs). To predict the concentration
of nutrients and waste products in the fluid leaving the MPS, we assume that the
total circulating volume is well-mixed. If the media feed is continuous, and 500
𝜇L are introduced each day, the media addition rate is .006 𝜇L/s; comparing to the
oxygenator and recirculation flow rates of 1 𝜇L/s or greater, it is reasonable to assume
the fresh media is well-mixed with the MPS volume.
5.1.3 Pump and Screw Layout
The Liverchip has 12 channels, with one pump per channel, each one in a straight
line from one end of the lane to the other. The layout of the screws and the pneu-
matic channels is therefore relatively straightforward. The 6xRL, while it has only
6 lanes, has 3 pumps per lane, and the recirculation channel must double back. In
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Figure 5-5: The 1 mL capacity fresh media reservoir features a sharp edge at the top
to confine the meniscus, and an intake hole that is offset from the wall to allow flow
rate measurement with the tool shown in Figure 5-9.
prototyping previous platforms with similar pumps and sealing lands, leaking had
been a significant problem, and a rule of thumb was developed that no more than
one sealing land should occur between two screws. The finite element study shown
in Figure 5-6 helped to qualitatively assess the design. Because this sealing is crit-
ical to proper function, it may be worthwhile to fabricate an SLA model for leak
testing before fabricating parts. A "polycarbonate-like" resin such as ACCURA 60
(3D Systems, Rock Hill, SC) should approximate the elastic modulus of polysulfone
enough to make meaningful design decisions. The screw layout for revision 2 is likely
conservative, and in fact initial fluid leak testing showed that one row of screws could
be removed without resulting in leaking when the platform was left pumping water
with food dye overnight. The clamping screws were tightened to 5 cNm. Tightening
to 15 cNm prevented the pumps from actuating; we hypothesize that this is caused by
the compressed polyurethane squeezing into the pump and valve chambers, causing
the membrane in the chamber to buckle.
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Figure 5-6: A pressure map of the sealing lands. In SolidWorks Simulation FEA of
the bottom plate alone, the top surface of each sealing land was fixed and a force of
20 N applied to the counterbore of each screw hole (hidden). This was not meant
as a quantitative measure of force, but helped to highlight any areas that might be
leak-prone, and to show the general distribution of pressure.
5.1.4 Pneumatic Bottom Plate
The pneumatic bottom plate is separated from the culture medium by the mem-
brane, and therefore does not have to be sterile or biocompatible. It is constructed
from two acrylic plates that are solvent-bonded together, after the internal pneu-
matic channels are machined. These internal channels connect air and vacuum from
the pneumatic fittings to the pump chambers.
Because of the high density of fasteners, and the presence of three pumps (each
of which requires three distribution channels), there was a very thin wall between
the screw clearance holes and the pneumatic channels on the Rev 2 pneumatic plate.
These walls broke during manufacturing, and upon receipt of the platforms all of
them leaked at multiple screw holes.
To resolve this issue, after the leak test described in Section 5.1.3 indicated that
a row of screws could be removed, an altered revision with a thicker wall was sent
for manufacture (the change is shown in Figure 5-7). The plates were not completed
at the time of writing, preventing testing with them, but they are currently being
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manufactured.
A) B)
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Figure 5-7: The revision 2 pneumatic manifold leaked between the horizontal pneu-
matic channels and the screw holes. The thin wall (470 𝜇m thick, 1mm tall) sepa-
rating the channels and screw holes fractured during manufacturing. The updated
pneumatic platforms remove one set of screws to allow a thicker wall (2 mm wide, 1
mm tall).
After machining, the fluidic and pneumatic plates were deburred using a dry
ice blasting service (Nitrofreeze, Worcester, MA). This freezes any small burrs from
machining and breaks them off with the impact of fine dry ice pellets, leaving a clean
surface without risk of grit remaining in the platforms. Figure 5-8 compares a pump
chamber before and after this process.
5.2 Testing
The scope of testing was limited by the leaking pneumatic plates, but it appears
that with a functional pneumatic plate the platform will meet the system-level re-
quirements described in Section 1.5: (1) the device is made cell and drug compatible
by using materials used and approved in existing platforms. For the short-term ex-
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A) B)
Figure 5-8: Inspection photos of pump chambers A) before and B) after cryo-
deburring. In this process, the top and bottom plates are dry ice blasted to remove
any burrs in the pumps or channels that might damage the membrane or dislodge
and plug the scaffold.
periments planned, Viton does not appreciably adsorb the compounds measured, and
absorption is entirely negligible. (2) The circulating volume is at the threshold of
500 𝜇L, varying on the order of 7% from well to well; the precise value depends on
measurement of the volume captured in the oxygenator, which is also flow-rate de-
pendent. (3) Media exchange can be programmed and can store 1 mL of fresh media,
and collect the waste by passive spilling. (4) The platform accommodates the same
sterile technique that has been used on other platforms, and can be similarly moved
between the incubator and Biological Safety Cabinet. (5) The platform accepts a
commercially-available Costal universal lid. (6) The pneumatic manifold integrates
with the existing hardware used in the Griffith lab.
5.2.1 Flowrate Measurement
To measure the recirculation flow rate, the tool shown in Figure 5-9 is inserted
in the central hole in the MPS bottom and pressed down such that the o-ring seals.
The MPS is filled with fluid such that the recirculation inlet does not run dry. Fluid
is pumped up through the tool, paused, and pumped back down, to obtain measure-
ments for upward and downward flow. The upward flow is therefore pushing against
a pressure head of less than 100 mm of water, and the downward flow is assisted by
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the same.
The inlet to the oxygenator does not allow the tool tip to seal, so the hole at the
start of the oxygenator spiral (see figure 5-3) is plugged using a pipette tip (20-200
𝜇L) that is plugged with silicone, and the flow rate is measured through the media
exchange inlet. The media exchange pump and valves are actively held open during
this test.
Figure 5-9: Flowrate test tool: the stainless tube is placed in 1mm fluid exit holes in
the MPS and media supply reservoir, such that the o-ring seals against the platform.
The time required for a fluid front to pass through the clear region of tubing between
the two brown clips is measured using a stopwatch. The tube volume of 39.3 𝜇L
between the brown clips is divided by this time to obtain the flow rate.
The measured flow rates across the 6 wells are shown in Figure 5-10. All pumps
measure about 10% lower than predicted based on nominal geometry. This may be
due to the pump chamber geometry being smaller than expected, in which case a
calibration factor can be added to the pump driving software, but it is necessary to
re-measure these flow rates with a pneumatic plate that does not leak and can provide
full actuation pressures.
5.2.2 Volume Recovery
To measure the circulating volume, the MPS and oxygenator are flooded with BSA
solution until spilling occurrs, and allowed to sit in the incubator for 1.5 hrs to come
to temperature. The pumps are off, and none of the scaffold assembly is present in
the MPS. After spilling, the volume remaining in the MPS and oxygenator is pipetted
onto a scale, and the mass remaining in each well was recorded. An average of 510±33
𝜇L was recovered (95% confidence). Subtracting the volume of the retaining ring and
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Figure 5-10: Measured flow rates, n=6: the MPS flow rate is measured in both
directions, and the oxygenator is measured only in its normal forward operating
direction. The intended flow rate was 1 𝜇L/s.
gasket (39 𝜇L), scaffold (25 𝜇L), and scaffold support (54 𝜇L), all measured calculated
from 3D CAD models, and adding the fluid trapped in channels (55 𝜇L, Figure 5-11)
and an estimated 50 𝜇L in the oxygenator when running, the circulating volume is
497±33 𝜇L. This meets the 500 𝜇L target closely. Note that this value depends on
an estimate of the oxygenator volume. While pipetting 50 𝜇L of BSA solution onto
the oxygenator produces a profile comparable to that during flow at 2 𝜇L/s, but
stopping flow and immediately aspirating is only able to recover 10-15 𝜇L. While the
true volume is likely between these values, a reliable method of directly measuring
trapped oxygenator volume directly would be valuable. Nonetheless, the oxygenator
volume is small compared to the overall 500 𝜇L volume.
5.2.3 Evaporation Test
Evaporation of media during cell culture is a critical consideration for an open
well platform. As the water evaporates, the concentration of the nutrients and waste
products increases, which will introduce error. Further, significant evaporation can
lead to drying of the MPS, causing either direct drying of the cells or pulling air
bubbles into the recirculation, either of which will adversely affect the cells.
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Figure 5-11: A 3D model of the fluid not measured by pipetting. The volume trapped
in the channels is 55 𝜇L. The volume in the media feed channel (grey) is not considered
part of the circulating volume, though some nutrient exchange by diffusion will occur.
We attempted an initial test of the evaporation rate on the revision 2 platform by
placing a silicone sheet over the bottom of the leaking pneumatic plate and wrapping
the seam with electrical tape. The measured evaporation rate (shown in Figure 5-12)
ranged from 144 to 220 𝜇L/day, and the outer two lanes show the most evaporation.
These values are much higher than the approximately 60 𝜇L/day observed on the
LiverChip (unpublished data). The increased evaporation at the edges is consistent
with the leaking pneumatic plate introducing dry air into the incubator and lowering
the relative humidity, as a gradient would develop between the humid environment
under the culture lid and the drier air outside it. The test must be repeated with
functioning pneumatic plates, but the updated revision 2B plates had not arrived
at the time of writing. We predict a lower evaporation rate with a properly sealed
peumatic plate.
5.3 Summary
Six replicate lanes are effectively packaged on a single platform that is compat-
ible with a standard tissue culture lid. The layout of pumps, channels, and screws
successfully seals the fluidic side while allowing separate pumping for perfusing the
cell scaffold, flowing through the oxygenator, and providing fresh media. The waste
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Figure 5-12: Evaporation test data: the evaporation rate appears significantly higher
than the 60 𝜇L/day seen on the LiverChip. The pneumatic plate was leaking dry
air into the incubator, and the experiment should therefore be repeated with a sealed
pneumatic plate when it is complete.
media spills passively into an effluent reservoir, which effectively controls fluid height,
limiting the circulating to the 500 𝜇L target. The peumatic plate fractured during
manufacture due to a thin wall, causing critical air leaks, but a revision 2B bottom
plate that is being manufactured at the time of writing is expected to resolve this
issue. At that point the evaporation and flow rate tests will be repeated.
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Chapter 6
Conclusions and Suggestions for
Future Work
6.1 Summary
We have designed, fabricated, and tested a free-surface oxygenator that uses the
tendency of fluid to wet corners in order to constrain the fluid flow with a short
effective diffusion length. Relative to the CN Bio LiverChip, which uses a wide, open
channel to oxygenate media, this method offers the advantages of self-emptying and
robustness to sloshing at a fraction of the volume. The primary cost of this method is
the extra circulation loop that it requires, but this cost brings other potential benefits,
such as closed-loop oxygen control. The revision 2 oxygenator performs equivalently
to the LiverChip oxygenation channel, though previous iterations show even better
performance. Additional performance could be gained by increasing the length or
total height of the oxygenator.
The additional oxygen circulation loop is designed to feed high-oxygen-concentration
media exiting the oxygenator directly to the cells, while feeding low-oxygen-concentration
media from the opposite side of the cell culture well directly into the oxygenator. Dur-
ing upward flow, this effect is observed at a flow rate of 2 𝜇L/s. During downward
flow, which is required for the first eight hours to seed the cells, the system is ex-
pected to behave like a fully mixed system, in which the oxygen concentration of
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media flowing to the cells is lower than at the output of the oxygenator.
A short-term solution to challenge of fluid bypassing the cell scaffold has been
developed, but it is limited in applicability due to concerns of Viton adsorbing certain
compounds. Many alternative solutions are outlined above, and we suggest designing
the scaffold attachment and the well geometry together, rather than designing an
attachment method to fit the existing well.
The final experimental validation of the platform depends on an updated pneu-
matic plate, which has not arrived at the time of writing. This updated plate is
designed to fix a thin wall that fractured during manufacture, rendering the original
pneumatic plates non-functional. With the arrival of these plates, after validating
the flow rates and measuring evaporation, we plan to run biological validation tests,
and then the platform can be used to investigate differences in cell culture with three
times lower circulating volumes.
6.2 Suggestions for Future Development
The suggestions below have two aims: first, to offer direction for the next steps this
research might take, and second, to highlight the assumptions made and approaches
taken during this work that should be revisited. While there is always an infinite
supply of improvements to be made–the data could be more comprehensive, each
behavior better characterized–we focus here on the end goal of providing a useful tool
for answering biological questions.
6.2.1 Requirements
Some of the stated design requirements are educated guesses by the biology team,
and the specific bounds of the necessary values are not definitively known. These
are mostly biological research questions rather than mechanical design challenges,
but there may be opportunities for mechanical design to support the experimental
process. Specifically, the 150 𝜇M oxygen concentration requirement is not rigorously
determined, and there are questions regarding the optimal oxygen concentration for
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hepatocyte culture (see, for example, Guo et al. [31]). In media lacking hemoglobin
or some other oxygen carrier, the minimum concentration feeding the cells must be
high enough that the down-stream cells are not hypoxic. This requirement could be
eased with the use of media that has additional oxygen storage capacity, mimicking
the role of hemoglobin in the blood.
The media exchange requirement also deserves assessment. The 6xRL platform
described in this thesis incorporates media exchange that relies on active input pump-
ing and passive output spilling. If media introduction flow rates are low enough (such
as for continuous media exchange), then it is reasonable to assume that fresh media
has been fully mixed into the system before the media mixture passively spills out
into the effluent. However, if batch exchange is desired, or the implementation of a
specific feeding schedule, a different media exchange system may be required. This
could take the form of active media collection, or a volume-limited closed-well system,
where introducing fluid volume at one end of the system must equal the fluid ejected
at the other, and the amounts of fresh and old media can be specifically accounted
for. Additionally, if the media source and effluent reservoirs are large enough, batch
exchange can be achieved by flushing some or all of the old media before introducing
new media.
The scaffold attachment sealing requirement of 40 kPa is likely excessive: the
maximum pressure measured in the system with a fully occluded scaffold could pro-
vide a better upper-bound requirement, or alternatively the pressure drop across the
scaffold at a 2 𝜇L/s flow rate, which is the peak flow rate at the scaffold predicted by
Inman [1] (p. 40).
6.2.2 Testing
As described above, additional work remains for testing the revised pneumatic
bottom plate when it is completed for flow rates and evaporation. When the fluidics
are proven to behave predictably, we should perform biological testing to validate the
platform for cell culture and subsequent experiments to assess the effect of low-volume
cell culture.
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6.2.3 Scaffold Attachment
To provide scaffold sealing without using an elastomer, we recommend designing
the sealing feature and well in tandem, rather than relying on a friction-based engage-
ment with the existing well. Packaging elastic elements to generate adequate forces
in both directions pushes the limits of available materials, at least for the 40 kPa
sealing requirement used. While a lower sealing requirement may make the friction
approach feasible, we recommend exploring the concepts outlined in Chapter 4 that
we excluded due to scheduling constraints.
6.2.4 Spiral Oxygenator
Several aspects of the spiral oxygenator should be explored if it is to be used in
further applications. First, we considered only polysulfone as a material, but plasma-
activated polystyrene or some other wetting material may offer better performance
and lower manufacturing cost. Further, the hypothesized effect of the corner radius
limiting diffusion depth and improving performance over a sharp corner has not been
tested. For machined prototypes, a small radius is required, but if parts are to be
molded, it is worth further investigating this phenomenon. Finally, the addition of
spontaneous capillary flow channels may be able to aid the initial wetting of the
platform. The conditions for such channels are described by Berthier et al. [22].
6.2.5 Media Exchange
The media exchange system on the 6xRL platform is actively pumped from a fresh
media reservoir, and the waste media passively spills over into an effluent collection
reservoir. If the flow rate of fresh media into the system is significantly lower than
the circulation and oxygenation flow rates, then it is reasonable to assume that the
system is fully mixed, and that the fluid spilling into the effluent is a uniform mixture
of old and new media. For continuous media exchange, where the media feed rate
is orders of magnitude lower than the recirculation rate, this fully-mixed assumption
applies.
126
For media feeding protocols other than continuous exchange, however, it is not
clear what ratio of old to new media is spilling over. Nor is it clear at what feed rate
we would observe a change from this fully mixed regime to only partial mixing. A
combination of modeling and experimental investigation (for example, by introducing
fluorescein dye with the fresh media) might reveal a safe operating range, where the
mixing assumption applies and the cell’s exposure to fresh media can be appropriately
predicted.
Another pumping channel for effluent collection could actively evacuate old media,
though care would need to be taken to ensure that a difference in flow rate between
the source and effluent pumps does not cause accumulation or depletion of media in
the system. An effluent intake similar to the MPS and Oxygenator inlets shown in
Figure 5-3 could avoid depleting the MPS by drawing air when the volume dropped
lower than the intake. This can also be solved by including and effluent spillway as
well as an effluent pump, and ensuring that the media input rate is slightly higher
than the media extraction rate.
Storing the fresh and effluent media off-platform could allow large enough volumes
to flush the system with fresh media, thereby achieving batch exchange, if this is
desired experimentally.
6.2.6 Closed-loop Oxygen Control
One advantage of having an oxygenator in a separate flow loop from the recir-
culation/perfusion pump, is that the oxygenator flow rate can be adjusted to adjust
the concentration of a mixed system to a desired level. An oxygen probe, such as
those made by Lucid Scientific (Atlanta, GA), could be integrated with the platform
to sense the oxygen concentration, which would feed back to the pump controller to
adjust the concentration. The concentration would be varied by increasing or de-
creasing the oxygenator flow rate. Questions such as where to place such a probe,
how to account for concentration differences across wells if the oxygenator pumps are
coupled, and what model to use for the oxygenator-cells system would all need to be
addressed.
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ṁO2 = f(QO2)
Desired
Concentration
Controller
Oxygen Probe
Pump
Oxygenator
+
MPS
CO2
QO2+
-
QO2
ṁO2
OxygenatorMPS
Oxygenator Pump
Oxygen Probe
Figure 6-1: Top) A block diagram of the proposed oxygen concentration feedback con-
trol. A controller uses the error between measured and desired oxygen concentrations
to adjust the oxygenator pump flow rate and thereby controll the oxygen concen-
tration in the MPS. Bottom) A schematic of the oxygenator and MPS, with the
oxygen probe measuring oxygen concentration in the MPS. Placement of the probe
requires careful consideration of local oxygen micro-environments, and depends on
experimental need.
6.2.7 Clamping and Sealing
One of the practical limitations of the 6xRL platform is the number of screws
holding the pneumatic and fluidic plates together. A significant improvement would
be an alternate clamping method using no screws or a substantially reduced number
of screws.
One reason for having so many screws in the present design is that because the
polyurethane membrane is so thin, it is stiff enough in compression that bending of
the acrylic and polysulfone plates becomes a consideration. For more details on the
stiffness characteristics of thin elastomer sheets, see [32]. If a thicker elastomer gasket
128
is placed under the membrane, deformation occurs primarily in the gasket, allowing
a less even distribution of forces, and potentially fewer screws. This gasket approach
was designed by Continuum Innovations (Boston, MA) and has been used in the Grif-
fith lab for some prototype platforms that did not seal adequately without them. The
main challenge is achieving deterministic and repeatable pump volumes: Continuum
addressed this with acrylic protrusions that hold the pump and valve geometry, but
that are surrounded by an elastomer to provide fluidic sealing. Such a gasket con-
figurations, if the sealing lands are significantly more compliant in compression than
the platform is in bending, could allow the use of significantly fewer screws, or even
a custom clamp. In a disposable platform, the plates could be temporarily clamped,
compressing the gasket, and then bonded, either ultrasonically or with adhesive. Af-
ter clamping is released, the bond would maintain a pressure seal. This might enable
use of membrane materials that cannot be effectively bonded.
6.2.8 Further Reducing Volume: a Closed Fluidic System
The 6xRL Rev2 volume of 500 𝜇L appears to be close to the lower limit achievable
in an open-well system. We believe that achieving substantially lower fluid volumes
with the same liver cell count will likely require a closed system without free surfaces,
where the volume is constrained and free of surface forces, and all constraints are
fully wetted. Design concepts for such a system are described below.
Overview
The platform proposed here is intended to be reusable, using the same basic
structure of a fluidic and pneumatic plate sandwiching a polyurethane membrane
that the 6xRL and LiverChip platforms use. We advise reusable platform for initial
development of the hardware itself, and for the iterative process of presenting a new
tool to biologists as it has lower cost and faster development time. A single-use device
can then be designed from the resuable design, incorporating new understanding and
user feedback. If the platform design is sufficiently solidified, the platform can be
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adapted to a disposable design, and work adapting the diaphragm pumps to a bonded
COC format is ongoing [33].
The membrane oxygenator, discussed in more detail below, uses a single in-line
circuit much like the CN Bio LiverChip. This feeds media directly from the oxygena-
tor to the cells in both flow directions. There are three main differences betwen this
platform and the LiverChip: (1) The use of a membrane oxygenator, (2) a media
exchange system, and (3) a cap that seals the MPS but can be removed to accom-
modate the existing cell seeding protocol. A cross section of one embodiment of this
proposed platform is shown in Figure 6-2, and a top level view is shown in Figure
6-3.
Universal Lid
Fresh Media IntakeWaste Media Euent
MPS Cap
Circulation/Oxygenator
Pump
Media Exchange
Pump
Oxygenator
Membrane
Oxygenator
Feed Channel*
Membrane Clamp
Scaold 
Assembly
Fluidic 
Capacitor
Figure 6-2: Each lane of the proposed closed-volume platform has media exchange
pulling from an external reservoir, an oxygenator membrane that is clamped in place
to provide a confined fluid path, an MPS cap to limit volume, and on-board pumping
(pneumatic plate not shown). The MPS cap and membrane are placed under a lid for
sterility, but this may be uncessary, depending on the sterile workflow. *Note that
oxygenator feed channel would actually be on the bottom plane with the other flow
channels. It is shown higher in this illustration for visibility.
We estimate that a circulating volume of 100-150 𝜇L is achievable with this con-
figuration. The volume trapped in circulation and the fluidic capacitor [1] is 55 𝜇L for
the 6xRL, as shown in Figure 5-11; this could likely be reduced to about 40 𝜇L. The
example oxygenator described below has a volume of 10 𝜇L, and for 8 mm diameter
130
MPS
MPS
MPS
MPS
Membrane Oxygenators
Universal Lid
Fresh Media IntakeWaste Media Euent
Figure 6-3: A top view of the proposed platform. We expect to accommodate 12 liver
cell culture wells on a single platform by staggering the oxygenators and MPS wells.
of exposed scaffold, we add an additional 50 𝜇L. Assuming the vertical fluid space
above the scaffold and through the scaffold support is 1 to 2 mm, a reasonable total is
100 to 150 𝜇L. This is potentially down to one tenth of the LiverChip volume, which
is more likely to reveal autocrine biomarkers than the 50 to 60% reduction achieved
with the 6xRl.
One additional consideration in this design is the height of the effluent, which sets
the system pressure, and avoiding a negative pressure on that line. The hydrophobic
membrane will resist fluid leaving the system, but may allow gas to enter if the
system is at lower than atmospheric pressure. The effluent exit to atmosphere should
therefore be located some amount above the system level.
Membrane Oxygenator
Membrane oxygenation is the only method we have found that would allow for
a volumetrically confined system. Hydrophobic nanoporous membranes (pore sizes
100 to 450 nm) made from polypropylene, polycarbonate, and PTFE appear to have
mass transfer coefficients exceeding that of a free surface, likely due to the velocity
profile near the membrane reducing the diffiusion boundary layer thickness [34]. Mass
transfer is reported to increase with contact angle; a higher oxygen transfer rate was
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observed with more hydrophobic materials.
As a conservative lower bound, we take the transfer rate through a free surface
and use the models described in Chapter 2. At 1 𝜇L/s , equation 2.21 suggests a
diffusion depth to exposed surface area ratio ℎ
𝐴
of .0005 [mm−1] will give an oxygena-
tion potential of 1.00 (i.e. fluid leaves the oxygenator fully saturated). Assuming a
2 mm wide two-sided oxygenation channel 100 𝜇m tall, that is oxygenated from top
and bottom, a 50 mm length is required to achieve ℎ
𝐴
= .0005 [mm−1]. The same
dimensions, but oxygenated from one side, would still give an oxygenation potential
of 0.998 (the model over-predicts the oxygenation potential, but this gives a rough
guide to appropriate dimensions). The hydraulic resistance 𝑅ℎ can be approximated
by
𝑅ℎ =
12𝐿𝜇
𝑤ℎ3
(6.1)
where L is the oxygenator length (0.050 m), 𝜇is the dynamic viscosity (0.78 mPa*s
for DMEM/F12 Medium at 37 °C) [35], 𝑤 is the channel width (0.002 m) and ℎ
is the channel height (0.0001 m) Multiplying by a flow rate of 1 𝜇L/s (1 × 10−9
m3/s) gives a pressure drop of less than 0.2 kPa, which the pneumatic pumps can
easily accommodate [19], and well below the pressure required to drive liquid across
a suitable membrane (for a 1 𝜇m pore diameter EPTFE membrane this pressure was
found to be on the order of 100 kPa [36]). The volume of fluid in the oxygenator would
be 10 𝜇L. This is just a representative example, but it shows that this approach is
quite feasible. Equation 2.21 allows quick prediction of oxygenator efficiency for a
wide range of channel dimensions.
One advantage of the membrane oxygenation method, in addition to allowing
a closed-volume system, is that flow is reversible, and the inline flow configuration
can be used. This reduces the number of pumps required, and feeds media from
the oxygenator directly to the cells when flowing upwards or downwards. While
it does not allow for real-time oxygen control by changing the flow rate–changing
the perfusion rate would change local shear stresses and might inadvertently alter
cell function–such control could potentially be achieved by controlling the local gas
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environment outside the membrane. A further advantage of micro- or nano-porous
membranes is that the oxygenator should act as a bubble trap, allowing gas to flow
out through the membrane, while retaining the fluid.
To allow removable fluidic sealing of the membrane, a clamping block with an
elastomeric gasket can compress the membrane in long channels, confining flow to
the uncompressed region. Potential configurations for such a design are shown in
Figure 6-4. Depending on the stiffness of the membrane relative to the width of the
channel, the channel height could be defined by deflection of the membrane alone,
or by a spacer. To make the system more compact, the oxygenator could have a
membrane on the top and bottom, but this results in a leak path that is challenging
to seal. For a single-sided oxygenator, two potential clamping plate configurations
are shown in Figure 6-5. In each of these clamped configurations, the membrane
hydrophobicity is advantageous. Even if there is a very small gap, surface tension
forces will prevent fluid from penetrating if the pressure differential is not extreme.
To gain the benefits of a double-sided oxygenator, while mitigating the leak path
shown in Figure 6-4-D, the membrane might be bonded to a secondary plug which
would seal to the platform. Such a configuration is shown in Figure 6-6. The top
membrane could then be bonded to this bottom membrane, eliminating the need for
a clamping block.
Media Exchange
If the media exchange inlet and outlet connect to the circulating fluid path on
either side of the recirculation pump, as shown in Figure 6-7, this allows greater
control over the media being added. Continuous media exchange, because the addition
flow rate is orders of magnitude smaller than the recirculation flow rate, will result
in a fully mixed system, so the fresh media exposure of the cells can be modeled
straightforwardly. Batch exchange is also possible, unlike in the 6xRL Rev2, by
sealing the recirculation pump while fresh media flushes the system. This system
would also allow programmed feeding schedules, so that a set amount of media could
be dosed at discrete times. This approach in general offers an easier system to model
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A) B)
C) D)
Leak Path
Elastomer
Figure 6-4: Membrane oxygenator cross sections with membrane shown in red and
fluid in blue: A) The fluid path width is defined by a clamping plate with an elas-
tomeric gasket to distribute pressure. The fluid path height is defined by deflection
of the membrane under pressure. B) If the membrane is stiff relative to the path
width, a spacer (crosshatched red) can be used. C) To halve the diffusion length and
make a more compact oxygenator, a double-membrane method could be used. D)
This double-membrane method does create a potential leak path that is challenging
to seal by clamping alone.
than an open system, allowing biologists to answer questions that depend on these
different dosing schemes. The inlet and outlet tubes are shown using standard HPLC
fittings, but other connectors could work as well. In packing multiple replicates on
a chip it may be advantageous to ensure that the effluent ports and the fresh media
supply ports are on opposite sides of the platform if they have to connect to an external
supply. Depending on packing and the relevant volumes, the reservoirs could also be
on the platform itself.
MPS Cap
The MPS must be sealed for this to be a closed-volume system, but in the current
seeding protocol, the hepatocytes are pipetted over the scaffold and allowed to settle.
This protocol could be accommodated by using a sealing cap, with either a solid
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Gasket (green)
Membrane (red)
Elastic Beam
Fastener
Clamp Block
Anchor
Figure 6-5: Top) A membrane (shown in red) could be clamped by a plate that has
narrow elastic beams connecting to posts that are bolted to the platform. The beams
would provide a spring element that would minimize bowing of the clamping plate,
and an elastomer gasket above the membrane would distribute the force to provide
an even sealing pressure to the membrane. Right) Such a clamping block, consisting
of several bars that confine fluid flow to the empty regions, could also be secured by
means of a fixed anchor at one end and an easy-to-use pivoting fastener (or multiple
of these) at the other end.
Bonded Interface
Bottom Membrane (red)
Tapered Plug
Through Hole
Figure 6-6: The lower membrane (shown in red) of a two-membrane oxygenator could
potentially be bonded to a tapered plug, which would seal to the platform below.
The top membrane could then be bonded or clamped to this bottom membrane. In a
disposable platform, the membrane might be bonded directly to the lower platform.
This depends on having a thermoplastic membrane material, such as polypropylene.
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Euent
Dead Volume
~1µL
MPS
Oxygenator
Media
Exchange
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Recirculation
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Figure 6-7: This media exchange configuration has media inlet and effluent on either
side of the recirculation pump. To feed media in, all chambers of the recirculation
pump are closed, blocking this path. The media exchange pump then adds the desired
amount of media through the oxygenator path. If media is flushed through the system,
the dead volume in the channels around the recirculation pump is on the order of 1
𝜇L. This could also be eliminated by pumping backwards for one or two cycles. Some
mixing between old and new media may occur in the MPS well.
surface or oxygenation membrane, that is placed into the well after the cells are
seeded. Two example caps are shown in Figure 6-8, one which inserts downward, and
another which slides from the side. It is important to ensure that the cap can be
applied without introducing bubbles, and that any fluid displaced by the cap can exit
either around the cap or out the effluent tube, so as not to creat flow or pressure pulses
that could displace the cells. The hepatocytes sink fairly quickly, so we expect that
either cap can safely be applied without significant risk of displacing the hepatocytes
with the media, but it would be necessary to confirm this empirically.
6.3 Conclusions
The 6xRL platform described in this thesis offers one solution to the challenge of
culturing relatively large numbers of hepatocytes in low fluid volumes. We conclude
that while the 6xRL volume could be further reduced, achieving volumes much less
than 400-500 𝜇L while using the same scaffold may require a closed-volume approach
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Figure 6-8: Caps for sealing the MPS volume after cells are added to the scaffold.
Left) A cap that is inserted downward will displace fluid around the sides, which
can be aspirated. Once seated, the cap will also push fluid out through the effluent
channel, which must remain open. The cap seals in place by a locking taper (shown),
screw threads, or a bayonet mount. Right) Alternatively, a sliding cap can cause less
disturbance to the fluid, pushing a fluid front off the top as it slides in place.
as described above.
The spiral oxygenator offers a novel method for achieving adequate oxygenation
at lower fluid volumes, and the downhill slope prevents the oxygenator from accu-
mulating fluid and depleting the MPS well. It is resistant to physical disturbances
and bubbles. It requires no extra parts and can be injection molded into a disposable
platform.
In addition to documenting the development process of this oxygenator and the
6xRL platform, this thesis provides a broad concept-space to consult when considering
oxygenator designs for other open-well fluidic applications, as well as methods for
improved scaffold sealing without the use of elastomers. These ideas, combined with
feedback from biological testing, will inform the design of future iterations of the
reduced volume liver cell culture platform.
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Appendix A
Oxygen Saturation
A.1 Oxygen Partial Pressure
The partial pressure of oxygen in the incubator—and therefore the dissolved oxy-
gen concentration in the media—depends on ambient total pressure and the partial
pressures of other gases present, such as CO2 and water vapor. These calculations
assume the media is water, and follow Wenger et al. [37], except that the humidity
in the incubators is near 80% relative humidity. The saturation vapor pressure at 37
°C is 6.28 kPa and and the room oxygen content is 20.9% by volume [37]. Incubator
CO2 is regulated at 5%, and atmospheric pressure is assumed to be 101.3 kPa. The
water vapor partial and CO2 pressure are therefore
𝑃H2O𝑔 = (80%)6.28 [kPa] = 5.024 [kPa] (A.1)
𝑃CO2 = (5%)101.3 [kPa] = 5.065 [kPa]. (A.2)
The balance of the partial pressures is taken up by oxygen and nitrogen, in the same
ratio as outside the incubator. The oxygen partial pressure in an incubator at 80%
humidity, 5% CO2, 1 atm, and 37 °C is then
𝑃O2 = (20.9%)(101.3− 5.065− 5.024) [kPa] = 19.1 [kPa]. (A.3)
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A.2 Dissolved Oxygen Concentration
Henry’s law relates the aqueous concentration 𝐶𝑎𝑞 of a gas to the partial pressure
𝑃 by a constant 𝐻(𝑐𝑝):
𝐶𝑎𝑞 = 𝐻
𝑐𝑝 × 𝑃. (A.4)
This constant 𝐻𝑐𝑝 is temperature dependent, and can be calculated [38] by
𝐻𝑐𝑝 = 𝐻𝑟𝑒𝑓 × exp
[︂
1700
(︂
1
𝑇
− 1
𝑇𝑟𝑒𝑓
)︂]︂
, (A.5)
where
𝐻𝑟𝑒𝑓 = 1.3× 10−3
[︂
M
atm
]︂
= 12.8× 10−6
[︂
M
kPa
]︂
(A.6)
𝑇𝑟𝑒𝑓 = 298 [K] (A.7)
The saturated concentration of dissolved oxygen in water at 37 °C (310 K) is
therefore
𝐶𝑠𝑎𝑡 = 10.2
[︂
𝜇M
kPa
]︂
× 19.1 [kPa] = 195 𝜇M. (A.8)
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Appendix B
Fourier Number and One-Term Model
The equations describing diffusion of heat through a solid of uniform properties
can be used by analogy to characterize mass diffusion. For unsteady heat transfer
in one dimension, without heat generation, the temperature profile in a material of
uniform thermal diffusivity 𝛼 is described by the heat equation:
𝜕𝑇
𝜕𝑡
= 𝛼
𝜕2𝑇
𝜕𝑥2
(B.1)
For mass transfer, the analogous one-dimensional equation without species formation
is known as Fick’s Second Law:
𝜕𝐶
𝜕𝑡
= 𝐷
𝜕2𝐶
𝜕𝑥2
(B.2)
where D is the diffusivity of the relevant species in the specific medium (𝐷𝑂2 =
3× 10−3[mm2s ] is the diffusion coefficient for oxygen in water at 37 °C).
Non-dimensionalizing with the characteristic time 𝜏 , depth ℎ, and saturation and
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intitial concentrations 𝐶𝑠𝑎𝑡 and 𝐶𝑜 yields
𝑡* =
𝑡
𝜏
, (B.3)
𝑥* =
𝑥
ℎ
, (B.4)
Φ =
𝐶 − 𝐶𝑠𝑎𝑡
𝐶𝑜 − 𝐶𝑠𝑎𝑡 . (B.5)
Note that Φ is distinct from 𝜑, the oxygenation potential, and
𝜑 = 1− Φ. (B.6)
The non-dimensionalized diffusion equation is then
𝜕Φ
𝜕𝑡*
=
𝐷𝜏
ℎ2
𝜕2Φ
𝜕𝑥*2
. (B.7)
The non-dimensional cluster 𝐷𝜏
ℎ2
is known as the Fourier number, notated for mass
transfer here as Fo𝑚. The Fourier number describes the ratio of the diffusive transport
rate ( 𝐷
ℎ2
) to the species storage rate ( 1
𝜏
). For the oxygenator described in Chapter 2,
the relevant time is the advection time constant 𝜏𝑎
Fo𝑚 =
𝐷𝑂2𝜏𝑎
ℎ2
=
𝐷𝑂2𝐴
2𝑄ℎ
=
𝐷𝑤
2𝑄ℎ
𝐿 (B.8)
where 𝐴 is the gas-liquid interface area, 𝑤 is the interface width, 𝑄 is the oxygenator
flow rate, and 𝐿 is the oxygenator length. The factor of two comes from the triangular
cross-section.
Glicksman and Lienhard [26] describe the normalized average temperature Θ using
a one-term approximation of the Fourier series that describes the developing concen-
tration profile for a rectangular slab:
Θ¯ =
𝑇 − 𝑇∞
𝑇𝑜 − 𝑇∞ = 𝐷1𝑒
−𝜆1Fo (B.9)
where 𝐷1 and 𝜆1 are coefficients that depend on the Biot number Bi, which describes
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the ratio of the heat transfer rates outside and inside the medium of interest. In the
case of oxygen mass transfer, the rate of oxygen transport through air is orders of
magnitude greater than that through water, so the Biot number is essentially infinite,
meaning that the concentration at the liquid surface is instantaneously brought to
saturation. We can similarly define a normalized averate concentration,
Φ¯ =
𝐶 − 𝐶𝑠𝑎𝑡
𝐶𝑜 − 𝐶𝑠𝑎𝑡 , (B.10)
where 𝐶 is a concentration spatially averaged from the interface at 𝑥 = 0 to the
opposite wall at 𝑥 = ℎ. Drawing an analogy between Θ¯ and Φ¯, and using the tabulated
coefficients [26] for Bi→∞ and plate geometry,
Φ¯ =
𝐶 − 𝐶𝑠𝑎𝑡
𝐶𝑜 − 𝐶𝑠𝑎𝑡 = 0.8106𝑒
−2.47Fo𝑚 . (B.11)
Using equation B.6 the oxygenation potential of the oxygenator is then
𝜑 =
𝐶 − 𝐶𝑜
𝐶𝑠𝑎𝑡 − 𝐶𝑜 = 1− 0.8106𝑒
−2.47Fo𝑚 . (B.12)
For a very large Biot number, Glicksman and Lienhard suggest that the one-term
approximation is appropriate for a Fourier number above 0.2. For the PSU spiral
oxygenator flowing at 1 𝜇L/s,
Fo𝑚 =
𝐷𝑤
2𝑄ℎ
𝐿 ≈ (3× 10
−3)(1)
2(1)(0.3)
× 𝐿 (B.13)
Fo𝑚 = 0.2 ⇒ 𝐿 ≈ 40 [mm]. (B.14)
For an oxygenator length of 175 mm, this suggests that the one-term solution is
appropriate for approximately 77% of the length.
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Appendix C
LiverChip Oxygenation Measurement
To measure oxygen consumption rates on the CN Bio LiverChip platform, we
designed and fabricated a custom lid that holds fiber optic probes (Lucid Scientific,
Atlanta, GA) submerged in the tail and 1 mm above the scaffold. To protect the
oxygen probes during sterilization, we assembled an acrylic shield, shown in Figure
C-1.
Figure C-1: A simple lid holds oxygen probes at the proper position and depth with
HPLC ferrule fittings. An acrylic shield prevents bending or other damage to the
probes during ETO sterilization of the assembly shown.
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Rat hepatocytes (250k) were seeded on the LiverChip, and assembled with the
custom lid. The oxygen readings over time are shown in Figure C-2. This was
a simple pilot test of only one channel to validate the sterilization process of the
oxygenation lid and obtain a ballpark figure for the consumption rates.
1 kPa partial pressure in the incubator environment corresponds to 10.2 𝜇M (see
Appendix A). Multiplying the concentration differences between tail and scaffold by
the flow rates, we see an oxygen consumption rate of approximately 100 pmol/s.
Two ubsequent measurements of 600k human hepatocytes from two different donors
showed a consumption rate of approximately 60 and 80 pmol/s (unpublished data).
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Figure C-2: Oxygenation measurments from one well of the LiverChip with 250k Rat
hepatocytes. Flow was downward through the scaffold for the first 8 hours, then
reversed to flow upward for the remainder of the experiment. After 48.5 hrs, the flow
rate was increased to 2 𝜇L/s.
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